{"content":"<li class=\"n-box-item date-title\" data-end=\"1575349199\" data-start=\"1575262800\" data-txt=\"Monday, December 23, 2019\">Monday, December  2, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3523228\" data-ts=\"1575343806\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSM\" target=\"_blank\">GSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523228-ferroglobe-eps-beats-0_08-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ferroglobe EPS beats by $0.08, misses on revenue</a></h4><ul><li>Ferroglobe (NASDAQ:<a href='https://seekingalpha.com/symbol/GSM' title='Ferroglobe PLC'>GSM</a>): Q3 Non-GAAP EPS of -$0.10 <font color=\"green\">beats by $0.08</font>; GAAP EPS of -$0.83 <font color=\"red\">misses by $0.66</font>.</li><li>Revenue of $381.7M (-27.2% Y/Y) <font color=\"red\">misses by $15.47M</font>.</li><li>Shares <font color=\"green\">+1.4%</font> AH.</li><li><a href=\"https://seekingalpha.com/pr/17715621-ferroglobe-reports-third-quarter-results-2019\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3523228\" data-linked=\"Ferroglobe EPS beats by $0.08, misses on revenue\" data-tweet=\"$GSM - Ferroglobe EPS beats by $0.08, misses on revenue https://seekingalpha.com/news/3523228-ferroglobe-eps-beats-0_08-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3523228-ferroglobe-eps-beats-0_08-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523219\" data-ts=\"1575330955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AER\" target=\"_blank\">AER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523219-aercapminus-1_6-holders-file-to-offer-up-to-4m-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AerCap -1.6% as holders file to offer up to 4M shares</a></h4><ul>   <li>AerCap (NYSE:<a href='https://seekingalpha.com/symbol/AER' title='AerCap Holdings N.V.'>AER</a>) is <font color=\"red\">down 1.6%</font> postmarket after a filing from holders to <a href=\"https://seekingalpha.com/filing/4721687\" target=\"_blank\">offer up to 4M ordinary shares</a>.</li>    <li>Waha AC Coöperatief and Avia Holding Limited (both tied to Waha Capital) are offering the shares through an underwritten public offering.</li>    <li>AerCap won't receive any proceeds from the sale of shares.</li>    <li>It also announced it's entered into an agreement to repurchase from Avia up to 2.43M ordinary shares, to be funded from cash on hand.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523219\" data-linked=\"AerCap -1.6% as holders file to offer up to 4M shares\" data-tweet=\"$AER - AerCap -1.6% as holders file to offer up to 4M shares https://seekingalpha.com/news/3523219-aercapminus-1_6-holders-file-to-offer-up-to-4m-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3523219-aercapminus-1_6-holders-file-to-offer-up-to-4m-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523216\" data-ts=\"1575328217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBL\" target=\"_blank\">CBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523216-cbl-suspends-all-dividends-expects-drop-in-2020-income\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBL suspends all dividends, expects drop in 2020 income</a></h4><ul><li>CBL Properties (NYSE:<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc'>CBL</a>) <font color=\"red\">-34.9%</font> after-hours on news it is <a href=\"https://seekingalpha.com/pr/17715441-cbl-properties-announces-suspension-common-preferred-stock-dividends\" target=\"_blank\">suspending all future dividends</a> on its common and preferred stock, citing the need to preserve free cash flow.</li><li>CBL says it anticipates a decline in net operating income in 2020 due to heightened retailer bankruptcies, restructurings and store closings in  2019.</li><li>The company says it will review the dividend suspension quarterly but expects the decision will remain in place until year-end 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523216\" data-linked=\"CBL suspends all dividends, expects drop in 2020 income\" data-tweet=\"$CBL - CBL suspends all dividends, expects drop in 2020 income https://seekingalpha.com/news/3523216-cbl-suspends-all-dividends-expects-drop-in-2020-income?source=tweet\" data-url=\"https://seekingalpha.com/news/3523216-cbl-suspends-all-dividends-expects-drop-in-2020-income\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>371&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523212\" data-ts=\"1575327692\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523212-vray-trvg-ubx-and-pb-among-after-hours-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VRAY, TRVG, UBX and PB among after hours movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/VRAY' title='ViewRay, Inc.'>VRAY</a> <font color=\"green\">+27.9%</font>. <a href='https://seekingalpha.com/symbol/TRVG' title='trivago N.V.'>TRVG</a> <font color=\"green\">+10.4%</font>. <a href='https://seekingalpha.com/symbol/ARDX' title='Ardelyx, Inc.'>ARDX</a> <font color=\"green\">+8.4%</font>. <a href='https://seekingalpha.com/symbol/BSBR' title='Banco Santander &#40;Brasil&#41; S.A.'>BSBR</a> <font color=\"green\">+7.2%</font>. <a href='https://seekingalpha.com/symbol/RTLR' title='Rattler Midstream LP'>RTLR</a> <font color=\"green\">+7.2%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/AGTC' title='Applied Genetic Technologies Corporation'>AGTC</a> <font color=\"red\">-9.1%</font>. <a href='https://seekingalpha.com/symbol/KOD' title='Kodiak Sciences Inc.'>KOD</a> <font color=\"red\">-7.9%</font>. <a href='https://seekingalpha.com/symbol/PB' title='Prosperity Bancshares, Inc.'>PB</a> <font color=\"red\">-4.6%</font>. <a href='https://seekingalpha.com/symbol/KRTX' title='Karuna Therapeutics, Inc.'>KRTX</a> <font color=\"red\">-4.6%</font>. <a href='https://seekingalpha.com/symbol/UBX' title='Unity Biotechnology, Inc.'>UBX</a> <font color=\"red\">-3.4%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523212\" data-linked=\"VRAY, TRVG, UBX and PB among after hours movers\" data-tweet=\"$VRAY $TRVG $ARDX - VRAY, TRVG, UBX and PB among after hours movers https://seekingalpha.com/news/3523212-vray-trvg-ubx-and-pb-among-after-hours-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523212-vray-trvg-ubx-and-pb-among-after-hours-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523187\" data-ts=\"1575324929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLUG\" target=\"_blank\">PLUG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523187-plug-power-launches-40m-share-public-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Plug Power launches 40M-share public offering</a></h4><ul><li>Plug Power (NASDAQ:<a href='https://seekingalpha.com/symbol/PLUG' title='Plug Power Inc.'>PLUG</a>) <font color=\"red\">-9.7%</font> after-hours, saying it has commenced a <a href=\"https://seekingalpha.com/pr/17715559-plug-power-inc-announces-proposed-public-offering-common-stock\" target=\"_blank\">public offering</a> of 40M common shares, with a 30-day option for the  underwriters to purchase up to an additional 6M shares.</li><li>Plug plans to use the proceeds from the offering for working  capital and other general corporate purposes, including capital  expenditures.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523187\" data-linked=\"Plug Power launches 40M-share public offering\" data-tweet=\"$PLUG - Plug Power launches 40M-share public offering https://seekingalpha.com/news/3523187-plug-power-launches-40m-share-public-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3523187-plug-power-launches-40m-share-public-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>77&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523186\" data-ts=\"1575324881\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KOD\" target=\"_blank\">KOD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523186-kodiak-sciences-down-9-after-hours-on-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kodiak Sciences down 9% after hours on equity offering</a></h4><ul><li>Kodiak Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/KOD' title='Kodiak Sciences Inc.'>KOD</a>) <a href=\"https://seekingalpha.com/pr/17715547-kodiak-sciences-announces-proposed-offering-common-stock\" target=\"_blank\">launches </a>a $250M public offering of common stock. Underwriters' over-allotment is an additional $37.5M of stock. Price, volume and terms have yet to be announced.</li><li>Shares down <font color=\"red\">9%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523186\" data-linked=\"Kodiak Sciences down 9% after hours on equity offering\" data-tweet=\"$KOD - Kodiak Sciences down 9% after hours on equity offering https://seekingalpha.com/news/3523186-kodiak-sciences-down-9-after-hours-on-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3523186-kodiak-sciences-down-9-after-hours-on-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523185\" data-ts=\"1575324664\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CWEN\" target=\"_blank\">CWEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523185-clearway-energy-launches-5_4m-share-public-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clearway Energy launches 5.4M-share public offering</a></h4><ul><li>Clearway Energy (NYSE:<a href='https://seekingalpha.com/symbol/CWEN' title='Clearway Energy, Inc.'>CWEN</a>) <font color=\"red\">-2.1%</font> after-hours, saying it has commenced a <a href=\"https://seekingalpha.com/pr/17715508-clearway-energy-inc-announces-proposed-offering-class-c-common-stock\" target=\"_blank\">public offering</a> of more than 5.4M shares of its Class C common stock.</li><li>CWEN says it plans to use the proceeds to partially fund the acquisition of the 527 MW Carlsbad Energy Center from an affiliate of Global Infrastructure Partners III, with any other proceeds going to general corporate purposes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523185\" data-linked=\"Clearway Energy launches 5.4M-share public offering\" data-tweet=\"$CWEN - Clearway Energy launches 5.4M-share public offering https://seekingalpha.com/news/3523185-clearway-energy-launches-5_4m-share-public-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3523185-clearway-energy-launches-5_4m-share-public-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523183\" data-ts=\"1575324577\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOMA\" target=\"_blank\">XOMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523183-xoma-launches-22m-rights-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xoma launches $22M rights offering</a></h4><ul><li>XOMA (NASDAQ:<a href='https://seekingalpha.com/symbol/XOMA' title='XOMA Corporation'>XOMA</a>) <a href=\"https://seekingalpha.com/pr/17715487-xoma-announces-commencement-rights-offering\" target=\"_blank\">commences </a>a rights offering to holders of its common stock, Series X Preferred and Series Y Preferred Stock. Investors will be entitled to purchase up to an aggregate of 1M common shares at $22.00 per share.</li><li>Today's close was $24.15.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523183\" data-linked=\"Xoma launches $22M rights offering\" data-tweet=\"$XOMA - Xoma launches $22M rights offering https://seekingalpha.com/news/3523183-xoma-launches-22m-rights-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3523183-xoma-launches-22m-rights-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523181\" data-ts=\"1575324107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SENS\" target=\"_blank\">SENS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523181-senseonics-launches-non-adjunctive-eversense-cgm-in-u-s\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Senseonics launches non-adjunctive Eversense CGM in U.S.</a></h4><ul><li>Senseonics (NYSEMKT:<a href='https://seekingalpha.com/symbol/SENS' title='Senseonics Holdings, Inc.'>SENS</a>) <a href=\"https://seekingalpha.com/pr/17715396-senseonics-launches-eversense-cgm-system-non-adjunctive-claim-u-s\" target=\"_blank\">announces </a>that users of the Eversense continuous glucose monitoring &#40;CGM&#41; system who download the new Eversense CGM mobile app can start dosing insulin based on readings from the device without the need of a confirmatory blood glucose measurement from a fingerstick sample.</li><li>Shares up <font color=\"green\">3%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523181\" data-linked=\"Senseonics launches non-adjunctive Eversense CGM in U.S.\" data-tweet=\"$SENS - Senseonics launches non-adjunctive Eversense CGM in U.S. https://seekingalpha.com/news/3523181-senseonics-launches-non-adjunctive-eversense-cgm-in-u-s?source=tweet\" data-url=\"https://seekingalpha.com/news/3523181-senseonics-launches-non-adjunctive-eversense-cgm-in-u-s\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523178\" data-ts=\"1575323809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRX\" target=\"_blank\">AMRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523178-fda-oks-amneals-generic-revatio-and-amicar-shares-up-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Amneal&#39;s generic Revatio and Amicar; shares up 2% after hours</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17715393-amneal-announces-approval-launch-generic-revatio-oral-suspension-generic-amicar-tablets\" target=\"_blank\">approves </a>Amneal Pharmaceuticals' (NYSE:<a href='https://seekingalpha.com/symbol/AMRX' title='Amneal Pharmaceuticals, Inc.'>AMRX</a>) generic versions of Pfizer's (NYSE:<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a>) Revatio (sildenafil citrate) Oral Suspension 10 mg/mL and Clover Pharms' Amicar (aminocaproic acid) Tablets USP, 500 mg. Commercialization will begin immediately.</li><li>Per IQVIA, the U.S. market for the former is ~$180M and ~$23M for the latter.</li><li>Shares up <font color=\"green\">2%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523178\" data-linked=\"FDA OKs Amneal&#39;s generic Revatio and Amicar; shares up 2% after hours\" data-tweet=\"$AMRX $PFE - FDA OKs Amneal&#39;s generic Revatio and Amicar; shares up 2% after hours https://seekingalpha.com/news/3523178-fda-oks-amneals-generic-revatio-and-amicar-shares-up-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3523178-fda-oks-amneals-generic-revatio-and-amicar-shares-up-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523176\" data-ts=\"1575323586\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTEC\" target=\"_blank\">TTEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523176-ttecminus-2_7-ceo-offers-3m-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TTEC -2.7% as CEO offers 3M shares</a></h4><ul><li>TTEC (NASDAQ:<a href='https://seekingalpha.com/symbol/TTEC' title='TTEC Holdings, Inc.'>TTEC</a>) <a href=\"https://seekingalpha.com/pr/17715528-ttec-holdings-inc-announces-secondary-offering-3000-000-shares-common-stock\" target=\"_blank\">commences</a> an underwritten secondary offering of 3M shares by selling shareholder and CEO Kenneth Tuchman.</li><li>Tuchman will grant underwriters a 30-day option to purchase up to 450K additional shares at the public offering price.</li><li>TTEC shares are <font color=\"red\">down 2.7%</font> after hours to $43.50.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523176\" data-linked=\"TTEC -2.7% as CEO offers 3M shares\" data-tweet=\"$TTEC - TTEC -2.7% as CEO offers 3M shares https://seekingalpha.com/news/3523176-ttecminus-2_7-ceo-offers-3m-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3523176-ttecminus-2_7-ceo-offers-3m-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523164\" data-ts=\"1575323206\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRAY\" target=\"_blank\">VRAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523164-viewray-up-37-after-hours-on-elekta-collaboration\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ViewRay up 37% after hours on Elekta collaboration</a></h4><ul><li>ViewRay (NASDAQ:<a href='https://seekingalpha.com/symbol/VRAY' title='ViewRay, Inc.'>VRAY</a>) is up <font color=\"green\">37%</font> after hours on the heels of its non-binding memorandum of understanding &#40;MOU&#41; with Elekta AB (<a href='https://seekingalpha.com/symbol/EKTAF' title='Elekta AB &#40;publ&#41;'>OTCPK:EKTAF</a>) for a <a href=\"https://seekingalpha.com/pr/17715365-viewray-announces-collaborations-elekta-medtronic\" target=\"_blank\">collaboration</a> aimed at advancing the knowledge and use of MR-guided radiation therapy. The partnership includes an investment by Elekta representing a 9.9% stake in ViewRay.</li><li>It has also signed a non-binding MOU with Medtronic (NYSE:<a href='https://seekingalpha.com/symbol/MDT' title='Medtronic plc'>MDT</a>) for a clinical collaboration aimed at exploring the benefits of the MRIdian MR-guided radiation therapy system. Medtronic has agreed to take a minority stake in ViewRay.</li><li>Both investments are contingent on ViewRay raising at least $75M in new capital. A <a href=\"https://seekingalpha.com/pr/17715374-viewray-announces-proposed-public-offering-common-stock\" target=\"_blank\">public offering</a> has been launched.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523164\" data-linked=\"ViewRay up 37% after hours on Elekta collaboration\" data-tweet=\"$VRAY $EKTAF $MDT - ViewRay up 37% after hours on Elekta collaboration https://seekingalpha.com/news/3523164-viewray-up-37-after-hours-on-elekta-collaboration?source=tweet\" data-url=\"https://seekingalpha.com/news/3523164-viewray-up-37-after-hours-on-elekta-collaboration\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523130\" data-ts=\"1575321526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COUP\" target=\"_blank\">COUP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523130-coupa-softwareminus-1_2-despite-beat-and-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coupa Software -1.2% despite beat-and-raise</a></h4><ul><li>Coupa Software (NASDAQ:<a href='https://seekingalpha.com/symbol/COUP' title='Coupa Software Incorporated'>COUP</a>) <font color=\"red\">-1.2%</font> reports <a href=\"https://seekingalpha.com/news/3523090-coupa-software-eps-beats-0_14-beats-revenue\" target=\"_blank\">Q3 beats</a> with subscription revenue up 49% Y/Y to $90.2M.</li><li>Q3 gross margin was 72.1% compared to the 71.3% consensus. Operating margin was 11.3% versus the 8.5% in last year's quarter.</li><li>Operating cash flow came in at $25.8M. FCF totaled $22.1M, up from $2.57M last year.</li><li>The Q4 outlook sees upside revenue of $101.5-102.5M with $91.5-92.5M in subscription revenue and upside EPS of $0.03-0.05.</li><li>The FY guidance raises the revenue view from $369-372M to $379.8-380.8M (consensus: $372.2M) with EPS of $0.34-0.37 (was: $0.11-16; consensus: $0.17).</li><li>Earnings call starts at 5 PM ET with a webcast <a href=\"https://c212.net/c/link/?t=0&amp;l=en&amp;o=2658158-1&amp;h=2100476846&amp;u=http%3A%2F%2Finvestors.coupa.com%2F&amp;a=http%3A%2F%2Finvestors.coupa.com\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17715402-coupa-software-reports-financial-results-third-quarter-fiscal-2020\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523130\" data-linked=\"Coupa Software -1.2% despite beat-and-raise\" data-tweet=\"$COUP - Coupa Software -1.2% despite beat-and-raise https://seekingalpha.com/news/3523130-coupa-softwareminus-1_2-despite-beat-and-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3523130-coupa-softwareminus-1_2-despite-beat-and-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523102\" data-ts=\"1575321145\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARWR\" target=\"_blank\">ARWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523102-arrowhead-down-3-after-hours-on-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arrowhead down 3% after hours on equity offering</a></h4><ul><li>Arrowhead Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals, Inc.'>ARWR</a>) slips <font color=\"red\">3%</font> after hours in reaction to its <a href=\"https://seekingalpha.com/pr/17715395-arrowhead-pharmaceuticals-announces-proposed-underwritten-offering-common-stock\" target=\"_blank\">public offering</a> of 4M common shares. Price and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523102\" data-linked=\"Arrowhead down 3% after hours on equity offering\" data-tweet=\"$ARWR - Arrowhead down 3% after hours on equity offering https://seekingalpha.com/news/3523102-arrowhead-down-3-after-hours-on-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3523102-arrowhead-down-3-after-hours-on-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523092\" data-ts=\"1575320890\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARDX\" target=\"_blank\">ARDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523092-ardelyx-conference-call-tomorrow-on-late-stage-tenapanor-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ardelyx conference call tomorrow on late-stage tenapanor data</a></h4><ul><li>Ardelyx (NASDAQ:<a href='https://seekingalpha.com/symbol/ARDX' title='Ardelyx, Inc.'>ARDX</a>) will host a conference call tomorrow, December 3, at 8:00 am ET to <a href=\"https://seekingalpha.com/pr/17715362-ardelyx-host-conference-call-december-3-review-results-pivotal-phase-3-phreedom-study\" target=\"_blank\">discuss results</a> from the Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03427125?lead=ardelyx&amp;phase=2&amp;rank=1\" target=\"_blank\">PHREEDOM</a> study evaluating tenapanor in chronic kidney disease patients on dialysis.</li><li>In September, the company <a href=\"https://seekingalpha.com/news/3496284-ardelyxs-tenapanor-successful-late-stage-study\" target=\"_blank\">announced </a>that the trial met the primary and all key secondary endpoints.</li><li>Shares up <font color=\"green\">1% </font>after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523092\" data-linked=\"Ardelyx conference call tomorrow on late-stage tenapanor data\" data-tweet=\"$ARDX - Ardelyx conference call tomorrow on late-stage tenapanor data https://seekingalpha.com/news/3523092-ardelyx-conference-call-tomorrow-on-late-stage-tenapanor-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3523092-ardelyx-conference-call-tomorrow-on-late-stage-tenapanor-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523082\" data-ts=\"1575320425\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRWD\" target=\"_blank\">CRWD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523082-crowdstrikeminus-5-on-target-cut-ahead-of-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CrowdStrike -5% on target cut ahead of earnings</a></h4><ul><li>Baird maintains a Neutral rating on CrowdStrike (NASDAQ:<a href='https://seekingalpha.com/symbol/CRWD' title='CrowdStrike Holdings, Inc.'>CRWD</a>) and lowers the target from $75 to $65.</li><li>The firm expects the company to continue to show \"robust growth\" in the Q3 report on December 5.</li><li>Analyst Jonathan Ruykhaver sees CRWD as \"well positioned\" to take significant market share, but says the company would have to \"meaningfully\" exceed expectations to justify the current valuation.</li><li>CrowdStrike shares are <font color=\"red\">down 5.2%</font> to $54.99.</li><li>CRWD has a Bullish average <a href=\"https://seekingalpha.com/symbol/CRWD/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523082\" data-linked=\"CrowdStrike -5% on target cut ahead of earnings\" data-tweet=\"$CRWD - CrowdStrike -5% on target cut ahead of earnings https://seekingalpha.com/news/3523082-crowdstrikeminus-5-on-target-cut-ahead-of-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3523082-crowdstrikeminus-5-on-target-cut-ahead-of-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523079\" data-ts=\"1575319617\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APA\" target=\"_blank\">APA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523079-apache-crashes-to-18-year-lows-after-incredibly-thin-suriname-well-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apache crashes to 18-year lows after &#39;incredibly thin&#39; Suriname well update</a></h4><ul><li>Apache (<a href='https://seekingalpha.com/symbol/APA' title='Apache Corporation'>APA</a> <font color='red'>-12.1%</font>) is by far today's biggest loser on the S&amp;P 500, plunging to its lowest levels since 2001 following a <a href=\"https://seekingalpha.com/news/3522878-apache-drill-deeper-first-suriname-well\" target=\"_blank\">disappointing update</a> of its first exploratory well in Block 58 offshore Suriname.</li><li>The update was a \"<a href=\"https://www.marketwatch.com/story/apaches-stock-plunges-toward-18-year-low-after-update-on-well-status-disappoints-2019-12-02\" target=\"_blank\">negative for the stock</a>,\" says SunTrust's Neal Dingmann, as APA did not discuss any production results from the first two tested Cretaceous targets and said it would drill an additional 700 meters to test a third target.</li><li>\"While we appreciate the desire to test multiple play concepts given promotion of the vast potential of this block, releasing the first update without any color on the results of the first two tests will not be taken well by the market,\" says Tudor Pickering's analyst team, which describes APA's exploratory Suriname project as \"<a href=\"https://www.wsj.com/articles/apache-shares-plunge-following-scant-update-on-south-american-oil-prospect-11575309078\" target=\"_blank\">among the most anticipated wells in the world</a>.\"</li><li>APA's update was \"<a href=\"https://finance.yahoo.com/news/apache-plunges-incredibly-thin-suriname-165620659.html\" target=\"_blank\">incredibly thin</a>,\" and going for a third zone could indicate that the first two were unsuccessful, says KeyBanc's Leo Mariani.</li><li>Morgan Stanley analyst Devin McDermott already was a skeptic, assigning odds that the Maka-1 well would show no commercial oil resource or a low gas discovery at 80%.</li><li>\"If there had been commercial hydrocarbons... detected with the initial well, we would have gotten that update from the company along with this release and there wouldn\u2019t be any need to drill deeper,\" McDermott tells Bloomberg.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523079\" data-linked=\"Apache crashes to 18-year lows after &#39;incredibly thin&#39; Suriname well update\" data-tweet=\"$APA - Apache crashes to 18-year lows after &#39;incredibly thin&#39; Suriname well update https://seekingalpha.com/news/3523079-apache-crashes-to-18-year-lows-after-incredibly-thin-suriname-well-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3523079-apache-crashes-to-18-year-lows-after-incredibly-thin-suriname-well-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>88&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523078\" data-ts=\"1575319537\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAVE\" target=\"_blank\">SAVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523078-spirit-airlines-attracts-new-bull\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spirit Airlines attracts a new bull</a></h4><ul> <li>Spirit Airlines (<a href='https://seekingalpha.com/symbol/SAVE' title='Spirit Airlines, Inc.'>SAVE</a> <font color='green'>+1.4%</font>) tracks higher after Buckingham Research upgrades the airline stock to a Buy rating after having it slotted at Neutral.</li> <li>The firm says it's making the bull call after raising 2020 estimates on Spirit.</li> <li>Analyst <a href=\"https://seekingalpha.com/symbol/SAVE/ratings/sell-side-ratings\" target=\"_blank\">scorecard</a> on SAVE: 6 Buy-equivalent ratings, 9 Neutral-equivalent ratings, 1 Sell-equivalent rating.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523078\" data-linked=\"Spirit Airlines attracts a new bull\" data-tweet=\"$SAVE - Spirit Airlines attracts a new bull https://seekingalpha.com/news/3523078-spirit-airlines-attracts-new-bull?source=tweet\" data-url=\"https://seekingalpha.com/news/3523078-spirit-airlines-attracts-new-bull\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523077\" data-ts=\"1575319348\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523077-expedia-tripadvisor-cut-mizuho-on-google-risk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Expedia, TripAdvisor cut at Mizuho on Google risk</a></h4><ul><li>Mizuho trims its Expedia (<a href='https://seekingalpha.com/symbol/EXPE' title='Expedia Group, Inc.'>EXPE</a> <font color='red'>-1.1%</font>) target by $15 to $100 and TripAdvisor (<a href='https://seekingalpha.com/symbol/TRIP' title='TripAdvisor, Inc.'>TRIP</a>) by $5 to $35.</li><li>The firm cites rising competition from Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet Inc.'>GOOG</a> <font color='red'>-0.9%</font>)(<a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet Inc.'>GOOGL</a> <font color='red'>-1%</font>), which has negatively impacted online travel agency \"organic search traffic in March, July and most recently in September.\"</li><li>Analyst James Lee expects the search engine traffic decline for Expedia to accelerate in Q4 while TRIP's traffic stabilizes. Mizuho does see \"negative leading indicators\" for TRIP's restaurants and attractions verticals.</li><li>Mizuho maintains Neutral ratings on Expedia and TripAdvisor. The average Sell Side ratings are Neutral for <a href=\"https://seekingalpha.com/symbol/TRIP/ratings/sell-side-ratings?s=trip\" target=\"_blank\">TRIP</a> and Bullish for <a href=\"https://seekingalpha.com/symbol/EXPE/ratings/sell-side-ratings\" target=\"_blank\">EXPE</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523077\" data-linked=\"Expedia, TripAdvisor cut at Mizuho on Google risk\" data-tweet=\"$EXPE $TRIP $GOOG - Expedia, TripAdvisor cut at Mizuho on Google risk https://seekingalpha.com/news/3523077-expedia-tripadvisor-cut-mizuho-on-google-risk?source=tweet\" data-url=\"https://seekingalpha.com/news/3523077-expedia-tripadvisor-cut-mizuho-on-google-risk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523076\" data-ts=\"1575318829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523076-major-scotus-ruling-on-gun-rights-appears-unlikely-for-now\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Major SCOTUS ruling on gun rights appears unlikely for now</a></h4><ul> <li>The Supreme Court appears unlikely to issue a major ruling that would have implications on broadening Second Amendment rights based off the arguments and discussion heard today in D.C.</li> <li>The fact that New York City already repealed the gun restriction law in question in the case, and with the New York State Legislature already passing a law to prohibit local governments in the state from enacting similar restrictions,  the desire of the high court to step in seems minimal. Justice Neil Gorsuch was reported to be the most interested in keeping the case alive, while Justice Brett Kavanaugh was silent during the arguments today. Chief Justice John Roberts' questions seemed to indicate that he thinks the question is moot.</li><li>Going into today's SCOTUS arguments, there was some speculation that a ruling would set a precedent that would be significant for other second amendment cases. That type of ruling is still very possible in another gun case that the Supreme Court takes up down the road.</li><li>Related stocks: American Outdoor Brands (<a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a> <font color=\"red\">-1.5%</font>), Sturm, Ruger (<a href='https://seekingalpha.com/symbol/RGR' title='Sturm, Ruger & Company, Inc.'>RGR</a>), Vista Outdoor (<a href='https://seekingalpha.com/symbol/VSTO' title='Vista Outdoor Inc.'>VSTO</a> <font color=\"red\">-1.8%</font>), Sportsman's Warehouse Holdings (<a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a> <font color=\"green\">+1.5%</font>).</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3523076\" data-linked=\"Major SCOTUS ruling on gun rights appears unlikely for now\" data-tweet=\"$AOBC $RGR $VSTO - Major SCOTUS ruling on gun rights appears unlikely for now https://seekingalpha.com/news/3523076-major-scotus-ruling-on-gun-rights-appears-unlikely-for-now?source=tweet\" data-url=\"https://seekingalpha.com/news/3523076-major-scotus-ruling-on-gun-rights-appears-unlikely-for-now\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523075\" data-ts=\"1575318715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADT\" target=\"_blank\">ADT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523075-bofa-hits-adt-sidelines-on-valuation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofA hits ADT sidelines on valuation</a></h4><ul><li>Bank of America downgrades ADT (NYSE:<a href='https://seekingalpha.com/symbol/ADT' title='ADT Inc.'>ADT</a>) from Buy to Neutral with a $9.50 price target. The company has a Neutral <a href=\"https://seekingalpha.com/symbol/ADT/ratings/quant-ratings\" target=\"_blank\">Quant rating</a>.</li><li>Analyst Gary Bisbee says the current valuation is \"far from demanding,\" but there are \"few catalysts for continued outperformance.\"</li><li>The analyst sees \"flattish\" revenue growth heading into next year with \"slightly lower\" earnings and cash flow thanks to rising investments.</li><li>ADT shares are <font color=\"red\">down 4%</font> to $8.87. ADT is <font color=\"green\">up 26%</font> YTD.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523075\" data-linked=\"BofA hits ADT sidelines on valuation\" data-tweet=\"$ADT - BofA hits ADT sidelines on valuation https://seekingalpha.com/news/3523075-bofa-hits-adt-sidelines-on-valuation?source=tweet\" data-url=\"https://seekingalpha.com/news/3523075-bofa-hits-adt-sidelines-on-valuation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523074\" data-ts=\"1575317961\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAVB\" target=\"_blank\">NAVB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523074-navidea-prevails-in-litigation-lender-shares-ahead-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Navidea prevails in litigation with lender; shares ahead 10%</a></h4><ul><li>Navidea Biopharmaceuticals (<a href='https://seekingalpha.com/symbol/NAVB' title='Navidea Biopharmaceuticals, Inc.'>NAVB</a> <font color=\"green\">+9.5%</font>) is up on almost 50% higher volume in reaction to its <a href=\"https://seekingalpha.com/pr/17715282-navidea-biopharmaceuticals-wins-summary-judgment-ohio\" target=\"_blank\">announcement </a>that an Ohio court has ruled in its favor in long-running lawsuit with lender Capital Royalty Partners &#40;CRG&#41;.</li><li>The court ruled that CRG collected excess remedies over and above $66.0M and must pay NAVB ~$4.3M plus interest.</li><li>The dispute arose in May 2016 with CRG <a href=\"https://seekingalpha.com/news/3425557-navidea-biopharma-proceed-lawsuit-financier\" target=\"_blank\">notified </a>the company that it was in default on a May 2015 loan and was entitled to certain remedies. The company claimed that it was fraudulently induced to settle in 2017.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523074\" data-linked=\"Navidea prevails in litigation with lender; shares ahead 10%\" data-tweet=\"$NAVB - Navidea prevails in litigation with lender; shares ahead 10% https://seekingalpha.com/news/3523074-navidea-prevails-in-litigation-lender-shares-ahead-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3523074-navidea-prevails-in-litigation-lender-shares-ahead-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523071\" data-ts=\"1575317228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523071-cloud-stocks-seeing-red\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cloud stocks seeing red</a></h4><ul><li>Cloud-based enterprise stocks drop today on continuing trade tensions with the First Trust Cloud Computing ETF (NASDAQ:<a href='https://seekingalpha.com/symbol/SKYY' title='First Trust Cloud Computing ETF'>SKYY</a>) <font color=\"red\">down 1.9%</font> compared to the <font color=\"red\">1.1% drop</font> for the tech sector (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>).</li><li>Decliners include Slack (<a href='https://seekingalpha.com/symbol/WORK' title='Slack Technologies, Inc.'>WORK</a> <font color='red'>-2.5%</font>), Zoom Video Communications (<a href='https://seekingalpha.com/symbol/ZM' title='Zoom Video Communications, Inc.'>ZM</a> <font color='red'>-7.4%</font>), Atlassian (<a href='https://seekingalpha.com/symbol/TEAM' title='Atlassian Corporation Plc'>TEAM</a> <font color='red'>-5.1%</font>), and Okta (<a href='https://seekingalpha.com/symbol/OKTA' title='Okta, Inc.'>OKTA</a> <font color='red'>-6.9%</font>).</li><li>SKYY is <font color=\"green\">up nearly 6%</font> this quarter and <font color=\"green\">26%</font> YTD.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523071\" data-linked=\"Cloud stocks seeing red\" data-tweet=\"$SKYY $XLK $WORK - Cloud stocks seeing red https://seekingalpha.com/news/3523071-cloud-stocks-seeing-red?source=tweet\" data-url=\"https://seekingalpha.com/news/3523071-cloud-stocks-seeing-red\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523068\" data-ts=\"1575316833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523068-marin-software-and-ameri-among-tech-gainers-sequans-communications-and-pintec-technology\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marin Software and AMERI among Tech gainers; Sequans Communications and Pintec Technology among losers</a></h4><ul><li><b>Gainers: </b>Marin Software (NASDAQ:<a href='https://seekingalpha.com/symbol/MRIN' title='Marin Software Incorporated'>MRIN</a>) <font color=\"green\">+11%</font>. AMERI Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRH' title='AMERI Holdings, Inc.'>AMRH</a>) <font color=\"green\">+8%</font>. trivago (NASDAQ:<a href='https://seekingalpha.com/symbol/TRVG' title='trivago N.V.'>TRVG</a>) <font color=\"green\">+8%</font>. Maxar Technologies (NYSE:<a href='https://seekingalpha.com/symbol/MAXR' title='Maxar Technologies Inc.'>MAXR</a>) <font color=\"green\">+6%</font>. Wireless Telecom Group (NYSEMKT:<a href='https://seekingalpha.com/symbol/WTT' title='Wireless Telecom Group, Inc.'>WTT</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Sequans Communications (NYSE:<a href='https://seekingalpha.com/symbol/SQNS' title='Sequans Communications S.A.'>SQNS</a>) <font color=\"red\">-23%</font>. Pintec Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/PT' title='Pintec Technology Holdings Limited'>PT</a>) <font color=\"red\">-16%</font>. The Trade Desk (NASDAQ:<a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk, Inc.'>TTD</a>) <font color=\"red\">-13%</font>. Sonim Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SONM' title='Sonim Technologies, Inc.'>SONM</a>) <font color=\"red\">-10%</font>. OptimizeRx (NASDAQ:<a href='https://seekingalpha.com/symbol/OPRX' title='OptimizeRx Corporation'>OPRX</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523068\" data-linked=\"Marin Software and AMERI among Tech gainers; Sequans Communications and Pintec Technology among losers\" data-tweet=\"$MRIN $AMRH $TRVG - Marin Software and AMERI among Tech gainers; Sequans Communications and Pintec Technology among losers https://seekingalpha.com/news/3523068-marin-software-and-ameri-among-tech-gainers-sequans-communications-and-pintec-technology?source=tweet\" data-url=\"https://seekingalpha.com/news/3523068-marin-software-and-ameri-among-tech-gainers-sequans-communications-and-pintec-technology\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523059\" data-ts=\"1575314145\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523059-vale-updates-estimates-investor-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vale updates estimates at investor day</a></h4><ul><li>Vale (<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='green'>+3.2%</font>) says it <a href=\"https://ca.reuters.com/article/businessNews/idCAKBN1Y623G\" target=\"_blank\">expects iron ore production to recover</a> in the coming years from a sharp  drop after the Brumadinho dam burst, rising to 390M-400M metric tons in 2022 from 340M mt in 2020 while anticipating $5B in capital spending in 2020-21.</li><li>In an <a href=\"http://www.vale.com/EN/investors/information-market/Press-Releases/ReleaseDocuments/1202_Proje%C3%A7%C3%B5es_ValeDay_FR_i.pdf\" target=\"_blank\">investor presentation</a>, Vale also guides for 2022 EBITDA of $15.5B-$23.5B and free cash flow of $7B-$14B.</li><li>Vale also says it will <a href=\"https://www.reuters.com/article/us-vale-dam/vale-decides-to-suspend-disposal-from-brucutu-mine-at-laranjeiras-dam-idUSKBN1Y623P\" target=\"_blank\">suspend disposals</a> of its Brucutu mine into the Laranjeiras dam for as long as two months, reducing the mine's iron ore production by 1.5M mt/month.</li><li>Finally, the company says it will <a href=\"https://www.ft.com/content/00392aec-152c-11ea-8d73-6303645ac406\" target=\"_blank\">set targets on reducing Scope 3 greenhouse gas emissions</a> from its products even after they have been sold, and will target net-zero emissions by 2050.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523059\" data-linked=\"Vale updates estimates at investor day\" data-tweet=\"$VALE - Vale updates estimates at investor day https://seekingalpha.com/news/3523059-vale-updates-estimates-investor-day?source=tweet\" data-url=\"https://seekingalpha.com/news/3523059-vale-updates-estimates-investor-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523058\" data-ts=\"1575313428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIGO\" target=\"_blank\">TIGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523058-millicomplus-1_8-amid-two-notch-upgrade-abg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Millicom +1.8% amid two-notch upgrade at ABG</a></h4><ul>   <li>Millicom International Cellular (<a href=\"http://seekingalpha.com/symbol/TIGO\" target=\"_blank\">TIGO</a> <font color=\"green\">+1.8%</font>) is higher today after an upgrade to Buy at ABG Sundal Collier, from Sell.</li>    <li>The two-notch upgrade comes with a price target of 500 kronor, now implying 15.5% upside from Stockholm pricing.</li>    <li>Overall, the <a href=\"https://seekingalpha.com/symbol/TIGO/ratings/sell-side-ratings\" target=\"_blank\">sell side is Very Bullish</a> on Millicom, while it has a <a href=\"https://seekingalpha.com/symbol/TIGO/ratings/quant-ratings\" target=\"_blank\">Quant Rating of Bearish</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523058\" data-linked=\"Millicom +1.8% amid two-notch upgrade at ABG\" data-tweet=\"$TIGO - Millicom +1.8% amid two-notch upgrade at ABG https://seekingalpha.com/news/3523058-millicomplus-1_8-amid-two-notch-upgrade-abg?source=tweet\" data-url=\"https://seekingalpha.com/news/3523058-millicomplus-1_8-amid-two-notch-upgrade-abg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523057\" data-ts=\"1575313382\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523057-saexploration-and-new-concept-energy-among-energy-materials-gainers-chaparral-energy-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SAExploration and New Concept Energy among Energy/Materials gainers; Chaparral Energy among Paringa Resources losers</a></h4><ul><li><b>Gainers: </b>SAExploration (NASDAQ:<a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a>) <font color=\"green\">+29%</font>. New Concept Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a>) <font color=\"green\">+8%</font>. Kimbell Royalty Partners (NYSE:<a href='https://seekingalpha.com/symbol/KRP' title='Kimbell Royalty Partners, LP'>KRP</a>) <font color=\"green\">+8%</font>. AK Steel (NYSE:<a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corporation'>AKS</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Chaparral Energy (NYSE:<a href='https://seekingalpha.com/symbol/CHAP' title='Chaparral Energy, Inc.'>CHAP</a>) <font color=\"red\">-20%</font>. Paringa Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/PNRL' title='Paringa Resources Limited'>PNRL</a>) <font color=\"red\">-17%</font>. Apache (NYSE:<a href='https://seekingalpha.com/symbol/APA' title='Apache Corporation'>APA</a>) <font color=\"red\">-13%</font>. NCS Multistage (NASDAQ:<a href='https://seekingalpha.com/symbol/NCSM' title='NCS Multistage Holdings, Inc.'>NCSM</a>) <font color=\"red\">-10%</font>. HighPoint Resources (NYSE:<a href='https://seekingalpha.com/symbol/HPR' title='HighPoint Resources Corporation'>HPR</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523057\" data-linked=\"SAExploration and New Concept Energy among Energy/Materials gainers; Chaparral Energy among Paringa Resources losers\" data-tweet=\"$SAEX $GBR $KRP - SAExploration and New Concept Energy among Energy/Materials gainers; Chaparral Energy among Paringa Resources losers https://seekingalpha.com/news/3523057-saexploration-and-new-concept-energy-among-energy-materials-gainers-chaparral-energy-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3523057-saexploration-and-new-concept-energy-among-energy-materials-gainers-chaparral-energy-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523054\" data-ts=\"1575312860\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAGDF\" target=\"_blank\">CAGDF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523054-centerra-halts-kumtor-operations-two-workers-missing-after-rockfall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Centerra halts Kumtor operations as two workers missing after rockfall</a></h4><ul><li>Centerra Gold (<a href='https://seekingalpha.com/symbol/CAGDF' title='Centerra Gold Inc.'>OTCPK:CAGDF</a> <font color='red'>-11.7%</font>) says it has <a href=\"https://www.bnnbloomberg.ca/centerra-halts-operations-at-kumtor-mine-after-two-workers-missing-following-rockfall-1.1356225\" target=\"_blank\">halted open pit mining operations</a> and is re-evaluating its mine plan at its Kumtor mine in the Kyrgyz Republic, as two workers are missing after a \"significant rock movement.\"</li><li>The company says the incident happened at the Lysii waste rock dump and it continues to search for the workers in \"very challenging circumstances.\"</li><li>The Kyrgyz government has said the Kumtor mine would produce 18.2 metric tons  of gold this year, topping an earlier forecast of 16.6-17.6 mt.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523054\" data-linked=\"Centerra halts Kumtor operations as two workers missing after rockfall\" data-tweet=\"$CAGDF - Centerra halts Kumtor operations as two workers missing after rockfall https://seekingalpha.com/news/3523054-centerra-halts-kumtor-operations-two-workers-missing-after-rockfall?source=tweet\" data-url=\"https://seekingalpha.com/news/3523054-centerra-halts-kumtor-operations-two-workers-missing-after-rockfall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523048\" data-ts=\"1575310819\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKS\" target=\"_blank\">AKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523048-steel-names-on-move-after-trump-tariffs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steel names on the move after Trump tariffs</a></h4><ul><li>Steel stocks are higher following Pres. Trump's <a href=\"https://seekingalpha.com/news/3522837-trump-slaps-tariffs-brazilian-steel-aluminum\" target=\"_blank\">renewal of tariffs</a> on steel and aluminum imports from Argentina and Brazil: <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corporation'>AKS</a> <font color=\"green\">+5.9%</font>, <a href='https://seekingalpha.com/symbol/TMST' title='TimkenSteel Corporation'>TMST</a> <font color=\"green\">+4.3%</font>, <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color=\"green\">+3%</font>, <a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color=\"green\">+1.4%</font>, <a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color=\"green\">+0.3%</font>.</li><li>Shares of Brazilian steelmakers <a href=\"https://www.bnnbloomberg.ca/everybody-wins-on-trump-tariffs-as-brazilian-steelmakers-rise-1.1356189\" target=\"_blank\">also are up</a>: <a href='https://seekingalpha.com/symbol/SID' title='Companhia Siderúrgica Nacional'>SID</a> <font color=\"green\">+3.9%</font>, <a href='https://seekingalpha.com/symbol/GGB' title='Gerdau S.A.'>GGB</a> <font color=\"green\">+1.9%</font>.</li><li>\"Argentina [tariffs] will not be that impactful to steel. But the new tariff on Brazil will raise the delivered costs of semi-finished steel for ArcelorMittal (<a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='red'>-1.4%</font>) in Alabama which imports slabs from Brazil,\" steel analyst Aldo Mazzaferro tells Barron's, adding that MT is the company <a href=\"https://www.barrons.com/articles/steel-stocks-rise-trump-tariffs-brazil-argentina-51575298984\" target=\"_blank\">most hurt by trade restrictions from Brazil</a>.</li><li>Brazil, along with Australia, dominates the global trade in steelmaking iron ore and ranks ninth in the world in steel output, producing ~40M mt/year.</li><li>On the flip side, Commercial Metals (<a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a> <font color='green'>+1.1%</font>) is <a href=\"https://www.bnnbloomberg.ca/trump-reinstating-brazil-steel-tariffs-to-help-u-s-rebar-makers-1.1356106\" target=\"_blank\">among the companies set to benefit</a> from the  curbs on Brazilian steel shipments, says BMO analyst Colin Hamilton.</li><li>ETF: <a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3523048\" data-linked=\"Steel names on the move after Trump tariffs\" data-tweet=\"$AKS $X $STLD - Steel names on the move after Trump tariffs https://seekingalpha.com/news/3523048-steel-names-on-move-after-trump-tariffs?source=tweet\" data-url=\"https://seekingalpha.com/news/3523048-steel-names-on-move-after-trump-tariffs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523046\" data-ts=\"1575310325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LILA\" target=\"_blank\">LILA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523046-liberty-latin-americaminus-3_8-scotiabank-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Liberty Latin America -3.8% as Scotiabank downgrades</a></h4><ul>   <li>Liberty Latin America (NASDAQ:<a href='https://seekingalpha.com/symbol/LILA' title='Liberty Latin America Ltd.'>LILA</a>) is <font color=\"red\">3.8% lower</font> following a downgrade to Sector Underperform at Scotiabank from Sector Perform.</li>    <li>Analyst Andres Coello has a $14 price target, tying a Street low and now implying 18% downside.</li>    <li>Sentiment overall is stronger, though, with <a href=\"https://seekingalpha.com/symbol/LILA/ratings/sell-side-ratings\" target=\"_blank\">sell-side analysts Bullish on average</a> and Seeking Alpha authors <a href=\"https://seekingalpha.com/symbol/LILA/ratings/author-ratings\" target=\"_blank\">Bullish as well</a>. The stock's <a href=\"https://seekingalpha.com/symbol/LILA/ratings/quant-ratings\" target=\"_blank\">Quant Rating is also Bullish</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523046\" data-linked=\"Liberty Latin America -3.8% as Scotiabank downgrades\" data-tweet=\"$LILA $LILAB $LILAK - Liberty Latin America -3.8% as Scotiabank downgrades https://seekingalpha.com/news/3523046-liberty-latin-americaminus-3_8-scotiabank-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3523046-liberty-latin-americaminus-3_8-scotiabank-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523045\" data-ts=\"1575310260\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASLN\" target=\"_blank\">ASLN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523045-aslan-pharma-launches-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ASLAN Pharma launches equity offering</a></h4><ul><li>On cue from its <a href=\"https://seekingalpha.com/news/3522830-aslan-pharma-85-percent-premarket-positive-aslan004-data\" target=\"_blank\">ASLAN004-stoked run-up</a>, ASLAN Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ASLN' title='ASLAN Pharmaceuticals Limited'>ASLN</a> <font color=\"green\">+49.2%</font>) <a href=\"https://seekingalpha.com/pr/17715211-aslan-pharmaceuticals-announces-proposed-public-offering-american-depositary-shares\" target=\"_blank\">commences </a>a public offering of American Depositary Shares (ADSs). Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523045\" data-linked=\"ASLAN Pharma launches equity offering\" data-tweet=\"$ASLN - ASLAN Pharma launches equity offering https://seekingalpha.com/news/3523045-aslan-pharma-launches-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3523045-aslan-pharma-launches-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523044\" data-ts=\"1575310163\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DSX\" target=\"_blank\">DSX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523044-diana-shippingminus-5-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Diana Shipping -5% after earnings</a></h4><ul> <li>Diana Shipping (<a href='https://seekingalpha.com/symbol/DSX' title='Diana Shipping Inc.'>DSX</a> <font color='red'>-5.3%</font>) slides after time charter revenue fell 13% Y/Y in <a href=\"https://seekingalpha.com/pr/17714626-diana-shipping-inc-reports-financial-results-third-quarter-nine-months-ended-september-30\" target=\"_blank\">Q3</a> to $53.5M.</li> <li>The decrease was due in part to the sale of two vessels in December of last year and five vessels this year. Lower average time charter rates during the quarter also factored in.</li> <li>Vessel operating expenses were down 3.6% during the quarter.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3522885-diana-shipping-eps-misses-0_02-beats-revenue\" target=\"_blank\">Diana Shipping EPS misses by $0.02, beats on revenue</a> (Dec. 2)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523044\" data-linked=\"Diana Shipping -5% after earnings\" data-tweet=\"$DSX - Diana Shipping -5% after earnings https://seekingalpha.com/news/3523044-diana-shippingminus-5-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3523044-diana-shippingminus-5-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523042\" data-ts=\"1575309813\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORTX\" target=\"_blank\">ORTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523042-ema-accepts-orchards-otlminus-200-application-for-rare-neurodegenerative-disorder\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EMA accepts Orchard&#39;s OTL-200 application for rare neurodegenerative disorder</a></h4><ul><li>Under accelerated assessment status, the European Medicines Agency &#40;EMA&#41; <a href=\"https://seekingalpha.com/pr/17714395-orchard-therapeutics-announces-filing-validation-marketing-authorization-application-european\" target=\"_blank\">accepts for review</a> Orchard Therapeutics' (<a href='https://seekingalpha.com/symbol/ORTX' title='Orchard Therapeutics plc'>ORTX</a> <font color=\"red\">-5.1%</font>) marketing application seeking approval of gene therapy OTL-200 for the treatment of <a href=\"https://rarediseases.info.nih.gov/diseases/3230/metachromatic-leukodystrophy\" target=\"_blank\">metachromatic leukodystrophy</a>, a rare inherited disorder characterized by the progressive deterioration of intellectual and motor skills caused by the accumulation of a type of fat in cells.</li><li>Under accelerated assessment, the review period is 150 days versus the standard 210 days. The action date should be around April 30, 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523042\" data-linked=\"EMA accepts Orchard&#39;s OTL-200 application for rare neurodegenerative disorder\" data-tweet=\"$ORTX - EMA accepts Orchard&#39;s OTL-200 application for rare neurodegenerative disorder https://seekingalpha.com/news/3523042-ema-accepts-orchards-otlminus-200-application-for-rare-neurodegenerative-disorder?source=tweet\" data-url=\"https://seekingalpha.com/news/3523042-ema-accepts-orchards-otlminus-200-application-for-rare-neurodegenerative-disorder\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523040\" data-ts=\"1575309615\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523040-nf-energy-saving-leads-industrial-gainers-capstone-turbine-and-aqua-metals-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NF Energy Saving leads industrial gainers; Capstone Turbine and Aqua Metals among losers</a></h4><ul><li><b>Gainers: </b>NF Energy Saving (NASDAQ:<a href='https://seekingalpha.com/symbol/BIMI' title='NF Energy Saving Corporation'>BIMI</a>) <font color=\"green\">+33%</font>. Hebron Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/HEBT' title='Hebron Technology Co., Ltd.'>HEBT</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Aqua Metals (NASDAQ:<a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals, Inc.'>AQMS</a>) <font color=\"red\">-43%</font>. Capstone Turbine (NASDAQ:<a href='https://seekingalpha.com/symbol/CPST' title='Capstone Turbine Corporation'>CPST</a>) <font color=\"red\">-7%</font>. Hovnanian Enterprises (NYSE:<a href='https://seekingalpha.com/symbol/HOV' title='Hovnanian Enterprises, Inc.'>HOV</a>) <font color=\"red\">-7%</font>. GMS (NYSE:<a href='https://seekingalpha.com/symbol/GMS' title='GMS Inc.'>GMS</a>) <font color=\"red\">-6%</font>. Concrete Pumping (NASDAQ:<a href='https://seekingalpha.com/symbol/BBCP' title='Concrete Pumping Holdings, Inc.'>BBCP</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523040\" data-linked=\"NF Energy Saving leads industrial gainers; Capstone Turbine and Aqua Metals among losers\" data-tweet=\"$BIMI $HEBT $AQMS - NF Energy Saving leads industrial gainers; Capstone Turbine and Aqua Metals among losers https://seekingalpha.com/news/3523040-nf-energy-saving-leads-industrial-gainers-capstone-turbine-and-aqua-metals-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523040-nf-energy-saving-leads-industrial-gainers-capstone-turbine-and-aqua-metals-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523038\" data-ts=\"1575309522\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523038-bat-group-leads-financial-gainers-leaf-group-and-yiren-digital-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bat Group leads financial gainers; Leaf Group and Yiren Digital among losers</a></h4><ul><li><b>Gainers:</b> Bat Group (NASDAQ:<a href='https://seekingalpha.com/symbol/GLG' title='Bat Group, Inc.'>GLG</a>) <font color=\"green\">+18%</font>. Yintech Investment Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/YIN' title='Yintech Investment Holdings Limited'>YIN</a>) <font color=\"green\">+9%</font>. EverQuote (NASDAQ:<a href='https://seekingalpha.com/symbol/EVER' title='EverQuote, Inc.'>EVER</a>) <font color=\"green\">+6%</font>. Codorus Valley Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/CVLY' title='Codorus Valley Bancorp, Inc.'>CVLY</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:</b> Weidai (NYSE:<a href='https://seekingalpha.com/symbol/WEI' title='Weidai Ltd.'>WEI</a>) <font color=\"red\">-11%</font>. CBL &amp; Associates Properties (NYSE:<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc'>CBL</a>) <font color=\"red\">-6%</font>. Leaf Group (NYSE:<a href='https://seekingalpha.com/symbol/LEAF' title='Leaf Group Ltd.'>LEAF</a>) <font color=\"red\">-6%</font>. Yiren Digital (NYSE:<a href='https://seekingalpha.com/symbol/YRD' title='Yiren Digital Ltd.'>YRD</a>) <font color=\"red\">-6%</font>. PagSeguro Digital (NYSE:<a href='https://seekingalpha.com/symbol/PAGS' title='PagSeguro Digital Ltd.'>PAGS</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523038\" data-linked=\"Bat Group leads financial gainers; Leaf Group and Yiren Digital among losers\" data-tweet=\"$GLG $YIN $EVER - Bat Group leads financial gainers; Leaf Group and Yiren Digital among losers https://seekingalpha.com/news/3523038-bat-group-leads-financial-gainers-leaf-group-and-yiren-digital-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523038-bat-group-leads-financial-gainers-leaf-group-and-yiren-digital-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523036\" data-ts=\"1575309144\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JE\" target=\"_blank\">JE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523036-just-energy-amends-senior-debt-covenant-suspends-preferred-dividend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Just Energy amends senior debt covenant, suspends preferred dividend</a></h4><ul><li>Just Energy (<a href='https://seekingalpha.com/symbol/JE' title='Just Energy Group Inc.'>JE</a> <font color='red'>-12.9%</font>) plunges after saying it will <a href=\"https://seekingalpha.com/pr/17714586-just-energy-announces-senior-debt-covenant-amendment-suspension-dividend-series-preferred\" target=\"_blank\">suspend the dividend payment</a> on its Series A preferred shares until it is permitted to declare and pay dividends under new agreements governing its facilities.</li><li>JE says it has amended its senior secured credit facility to increase the senior debt to EBITDA covenant ratio to 2-to-1 from 1.5-to-1 and its senior unsecured term loan facility to  increase the senior debt to EBITDA covenant ratio to 2.15-to-1 from 1.65-to-1.</li><li>JE says the agreements governing both facilities were changed to restrict  the declaration and payment of dividends on its 8.5% Series A  Fixed-to-Floating Rate Cumulative Redeemable Perpetual Preferred Shares  until the company's senior debt to EBITDA  ratio is no more than 1.5-to-1 for two consecutive fiscal quarters.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523036\" data-linked=\"Just Energy amends senior debt covenant, suspends preferred dividend\" data-tweet=\"$JE - Just Energy amends senior debt covenant, suspends preferred dividend https://seekingalpha.com/news/3523036-just-energy-amends-senior-debt-covenant-suspends-preferred-dividend?source=tweet\" data-url=\"https://seekingalpha.com/news/3523036-just-energy-amends-senior-debt-covenant-suspends-preferred-dividend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523033\" data-ts=\"1575308449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523033-roku-apa-ormp-and-clsd-among-notable-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ROKU, APA, ORMP and CLSD among notable midday movers</a></h4><ul><li><strong>Gainers: </strong>Kodiak Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/KOD' title='Kodiak Sciences Inc.'>KOD</a>) <font color=\"green\">+70%</font>.</li><li>ASLAN Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ASLN' title='ASLAN Pharmaceuticals Limited'>ASLN</a>) <font color=\"green\">+63%</font>.</li><li>Cortexyme (NASDAQ:<a href='https://seekingalpha.com/symbol/CRTX' title='Cortexyme, Inc.'>CRTX</a>) <font color=\"green\">+32%</font>.</li><li>NF Energy Saving (NASDAQ:<a href='https://seekingalpha.com/symbol/BIMI' title='NF Energy Saving Corporation'>BIMI</a>) <font color=\"green\">+31%</font>.</li><li>Oramed Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ORMP' title='Oramed Pharmaceuticals Inc.'>ORMP</a>) <font color=\"green\">+20%</font>.</li><li>Clearside Biomedical (NASDAQ:<a href='https://seekingalpha.com/symbol/CLSD' title='Clearside Biomedical, Inc.'>CLSD</a>) <font color=\"green\">+19%</font>.</li><li>SAExploration (NASDAQ:<a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a>) <font color=\"green\">+19%</font>.</li><li>Bat Group (NASDAQ:<a href='https://seekingalpha.com/symbol/GLG' title='Bat Group, Inc.'>GLG</a>) <font color=\"green\">+18%</font>.</li><li>China Automotive Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CAAS' title='China Automotive Systems, Inc.'>CAAS</a>) <font color=\"green\">+16%</font>.</li><li>Brainsway (NASDAQ:<a href='https://seekingalpha.com/symbol/BWAY' title='Brainsway Ltd.'>BWAY</a>) <font color=\"green\">+16%</font>.</li><li><strong>Losers: </strong>Aqua Metals (NASDAQ:<a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals, Inc.'>AQMS</a>) <font color=\"red\">-42%</font>.</li><li>Akers Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/AKER' title='Akers Biosciences, Inc.'>AKER</a>) <font color=\"red\">-19%</font>.</li><li>Sequans Communications (NYSE:<a href='https://seekingalpha.com/symbol/SQNS' title='Sequans Communications S.A.'>SQNS</a>) <font color=\"red\">-17%</font>.</li><li>Molecular Templates (NASDAQ:<a href='https://seekingalpha.com/symbol/MTEM' title='Molecular Templates, Inc.'>MTEM</a>) <font color=\"red\">-16%</font>.</li><li>Paringa Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/PNRL' title='Paringa Resources Limited'>PNRL</a>) <font color=\"red\">-16%</font>.</li><li>Pintec Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/PT' title='Pintec Technology Holdings Limited'>PT</a>) <font color=\"red\">-16%</font>.</li><li>Roku (NASDAQ:<a href='https://seekingalpha.com/symbol/ROKU' title='Roku, Inc.'>ROKU</a>) <font color=\"red\">-15%</font>.</li><li>Lexicon Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a>) <font color=\"red\">-14%</font>.</li><li>Apache (NYSE:<a href='https://seekingalpha.com/symbol/APA' title='Apache Corporation'>APA</a>) <font color=\"red\">-14%</font>.</li><li>Just Energy (NYSE:<a href='https://seekingalpha.com/symbol/JE' title='Just Energy Group Inc.'>JE</a>) <font color=\"red\">-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523033\" data-linked=\"ROKU, APA, ORMP and CLSD among notable midday movers\" data-tweet=\"$KOD $ASLN $CRTX - ROKU, APA, ORMP and CLSD among notable midday movers https://seekingalpha.com/news/3523033-roku-apa-ormp-and-clsd-among-notable-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523033-roku-apa-ormp-and-clsd-among-notable-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523031\" data-ts=\"1575307199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523031-bofa-examines-sprint-t-mobile-odds-trial-looms\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofA examines Sprint/T-Mobile odds as trial looms</a></h4><ul>   <li>With a trial set to begin next Monday over several states' challenge to the proposed merger of T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"red\">-1.6%</font>) and Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color=\"red\">-5.1%</font>), time for settling the deal is growing short (if it's possible at all to come to terms with New York Attorney General Letitia James, leading the states).</li>    <li>It's difficult to evaluate the deal's chances looking at Sprint's price, BofA's David Barden says, noting that it's conflating the odds of success with a renegotiated price.</li>    <li>The states likely have a strong case going into the trial, he notes, but the high-yield market appears more positive on the merger's success (pricing in an 80% chance) than the equity market (around 50%, he says).</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3523031\" data-linked=\"BofA examines Sprint/T-Mobile odds as trial looms\" data-tweet=\"$TMUS $S - BofA examines Sprint/T-Mobile odds as trial looms https://seekingalpha.com/news/3523031-bofa-examines-sprint-t-mobile-odds-trial-looms?source=tweet\" data-url=\"https://seekingalpha.com/news/3523031-bofa-examines-sprint-t-mobile-odds-trial-looms\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523029\" data-ts=\"1575307011\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPMC\" target=\"_blank\">BPMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523029-blueprint-medicines-down-7-on-bearish-call-deutsche-bank\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blueprint Medicines down 7% on bearish call at Deutsche Bank</a></h4><ul><li>Blueprint Medicines (<a href='https://seekingalpha.com/symbol/BPMC' title='Blueprint Medicines Corporation'>BPMC</a> <font color=\"red\">-6.8%</font>) was down as over <font color=\"red\">9% </font>intraday in apparent response to a new \"Sell Catalyst Call\" at Deutsche Bank. Analyst Konstantinos Aprilakis lacks confidence that initial data from a Phase 2 study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03731260?cond=Indolent+Systemic+Mastocytosis&amp;spons=blueprint+medicines&amp;draw=2&amp;rank=1\" target=\"_blank\">PIONEER</a>, evaluating avapritinib in a rare disorder called <a href=\"https://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=EN&amp;Expert=98848\" target=\"_blank\">indolent systemic mastocytosis</a> will be positive.</li><li>In late October, shares briefly sold off on the <a href=\"https://seekingalpha.com/news/3510092-blueprint-medicines-9-percent-extended-timeline-avapritinib-4th-line-gist\" target=\"_blank\">news</a> that the FDA's review of its application for avapritinib in third- and fourth-line gastrointestinal stromal tumor &#40;GIST&#41; will likely be delayed past the February 14, 2020 PDUFA date since the agency wants to include topline results from the Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03465722?term=NCT03465722&amp;draw=2&amp;rank=1\" target=\"_blank\">VOYAGER</a> trial, expected to be available in Q2 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523029\" data-linked=\"Blueprint Medicines down 7% on bearish call at Deutsche Bank\" data-tweet=\"$BPMC - Blueprint Medicines down 7% on bearish call at Deutsche Bank https://seekingalpha.com/news/3523029-blueprint-medicines-down-7-on-bearish-call-deutsche-bank?source=tweet\" data-url=\"https://seekingalpha.com/news/3523029-blueprint-medicines-down-7-on-bearish-call-deutsche-bank\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523015\" data-ts=\"1575306032\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STWD\" target=\"_blank\">STWD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523015-starwood-property-trust-gains-after-wells-fargo-callout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Starwood Property Trust gains after Wells Fargo callout</a></h4><ul> <li>Wells Fargo initiates coverage on Starwood Property Trust (<a href='https://seekingalpha.com/symbol/STWD' title='Starwood Property Trust, Inc.'>STWD</a> <font color='green'>+1%</font>) with an Outperform rating on its view that shares look cheap.</li> <li>WF calls Starwood Properties Trust one of the best positioned commercial real estate finance companies that also has a history of successfully incubating new businesses. The price-to-book ratio on STWD is also highlighted as low in comparison to peers.</li> <li>\"We believe this discount is too wide even when factoring in a complexity discount; STWD's div yield of ~8% is 600+ bps over the 10-yr yield vs historical 250-350 pre-crisis periods,\" notes the firm.</li> <li>\"Tactically, we like the stocks towards year end/Jan as deal flow is seasonally high and spreads can tend to tighten in Jan.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523015\" data-linked=\"Starwood Property Trust gains after Wells Fargo callout\" data-tweet=\"$STWD - Starwood Property Trust gains after Wells Fargo callout https://seekingalpha.com/news/3523015-starwood-property-trust-gains-after-wells-fargo-callout?source=tweet\" data-url=\"https://seekingalpha.com/news/3523015-starwood-property-trust-gains-after-wells-fargo-callout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523013\" data-ts=\"1575306003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EPZM\" target=\"_blank\">EPZM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523013-epizyme-down-6-ahead-of-tazemetostat-ad-com-review\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Epizyme down 6% ahead of tazemetostat Ad Com review</a></h4><ul><li>Epizyme (<a href='https://seekingalpha.com/symbol/EPZM' title='Epizyme, Inc.'>EPZM</a> <font color=\"red\">-5.9%</font>) slips on average volume as broad market selling weighs on shares. The stock had rallied over <font color=\"green\">70%</font> since early October before today's action.</li><li>The FDA's Oncologic Drugs Advisory Committee will <a href=\"https://seekingalpha.com/pr/17715044-epizyme-announces-fda-advisory-committee-meeting-review-tazemetostat-treatment-patients\" target=\"_blank\">meet </a>on Wednesday, December 18, to review and discuss the company's marketing application seeking accelerated approval of tazemetostat for metastatic or locally advanced epithelioid sarcoma patients not eligible for curative surgery.</li><li>The agency's action date is January 23, 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523013\" data-linked=\"Epizyme down 6% ahead of tazemetostat Ad Com review\" data-tweet=\"$EPZM - Epizyme down 6% ahead of tazemetostat Ad Com review https://seekingalpha.com/news/3523013-epizyme-down-6-ahead-of-tazemetostat-ad-com-review?source=tweet\" data-url=\"https://seekingalpha.com/news/3523013-epizyme-down-6-ahead-of-tazemetostat-ad-com-review\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523010\" data-ts=\"1575305979\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523010-tenneco-and-china-automotive-systems-in-consumer-gainers-beyond-meat-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tenneco and China Automotive Systems in consumer gainers; Beyond Meat among losers</a></h4><ul><li><b>Gainers: </b>China Automotive Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CAAS' title='China Automotive Systems, Inc.'>CAAS</a>) <font color=\"green\">+14%</font>. Tenneco (NYSE:<a href='https://seekingalpha.com/symbol/TEN' title='Tenneco Inc.'>TEN</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>TDH Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PETZ' title='TDH Holdings, Inc.'>PETZ</a>) <font color=\"red\">-7%</font>. Tuniu (NASDAQ:<a href='https://seekingalpha.com/symbol/TOUR' title='Tuniu Corporation'>TOUR</a>) <font color=\"red\">-6%</font>. Nautilus (NYSE:<a href='https://seekingalpha.com/symbol/NLS' title='Nautilus, Inc.'>NLS</a>) <font color=\"red\">-6%</font>. Beyond Meat (NASDAQ:<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a>) <font color=\"red\">-6%</font>. New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523010\" data-linked=\"Tenneco and China Automotive Systems in consumer gainers; Beyond Meat among losers\" data-tweet=\"$CAAS $TEN $PETZ - Tenneco and China Automotive Systems in consumer gainers; Beyond Meat among losers https://seekingalpha.com/news/3523010-tenneco-and-china-automotive-systems-in-consumer-gainers-beyond-meat-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523010-tenneco-and-china-automotive-systems-in-consumer-gainers-beyond-meat-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523004\" data-ts=\"1575305405\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PDSB\" target=\"_blank\">PDSB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523004-pds-bio-up-16-ahead-of-versamune-presentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PDS Bio up 16% ahead of Versamune presentation</a></h4><ul><li>Thinly traded nano cap PDS Biotechnology (<a href='https://seekingalpha.com/symbol/PDSB' title='PDS Biotechnology Corporation'>PDSB</a> <font color=\"green\">+15.5%</font>) is up on modestly higher volume, 100K shares, on no particular news.</li><li>On Wednesday, December 4, CMO Lauren Wood, M.D. will deliver a <a href=\"https://seekingalpha.com/pr/17709873-pds-biotechnology-present-world-vaccine-and-immunotherapy-congress-west-coast-2019\" target=\"_blank\">presentation</a> on cancer immunotherapy platform <a href=\"http://www.pdsbiotech.com/versamune-platform/\" target=\"_blank\">Versamune </a>at the World Vaccine &amp; Immunotherapy Congress West Coast in San Francisco at 3 pm PT.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523004\" data-linked=\"PDS Bio up 16% ahead of Versamune presentation\" data-tweet=\"$PDSB - PDS Bio up 16% ahead of Versamune presentation https://seekingalpha.com/news/3523004-pds-bio-up-16-ahead-of-versamune-presentation?source=tweet\" data-url=\"https://seekingalpha.com/news/3523004-pds-bio-up-16-ahead-of-versamune-presentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523002\" data-ts=\"1575304910\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRTX\" target=\"_blank\">CRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523002-cortexyme-up-27-ahead-of-evercore-event\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cortexyme up 27% ahead of Evercore event</a></h4><ul><li>Thinly traded Cortexyme (<a href='https://seekingalpha.com/symbol/CRTX' title='Cortexyme, Inc.'>CRTX</a> <font color=\"green\">+27.3%</font>) is up on triple normal volume, albeit on turnover of only 177K shares, ahead of tomorrow's fireside chat by CEO Casey Lynch at Evercore ISI's HealthCONx Conference in Boston at 2 pm ET.</li><li>The company's lead candidate is <a href=\"https://seekingalpha.com/news/3450484-cortexyme-readies-ipo\" target=\"_blank\">COR388</a>, a brain-penetrating small molecule gingipain inhibitor for the potential treatment of Alzheimer's disease &#40;AD&#41;.</li><li>Gingipains are toxic enzymes secreted by a certain bacterium present in 90% of the brains of AD sufferers.</li><li>A Phase 2/3 study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03823404?spons=cortexyme&amp;draw=2&amp;rank=1\" target=\"_blank\">GAIN</a>, is in process.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523002\" data-linked=\"Cortexyme up 27% ahead of Evercore event\" data-tweet=\"$CRTX - Cortexyme up 27% ahead of Evercore event https://seekingalpha.com/news/3523002-cortexyme-up-27-ahead-of-evercore-event?source=tweet\" data-url=\"https://seekingalpha.com/news/3523002-cortexyme-up-27-ahead-of-evercore-event\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522980\" data-ts=\"1575304057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AQMS\" target=\"_blank\">AQMS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522980-aqua-metals-battery-processing-plant-ravaged-fire\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aqua Metals&#39; battery processing plant ravaged by fire</a></h4><ul><li>Aqua Metals (<a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals, Inc.'>AQMS</a> <font color='red'>-46.3%</font>) plunges to all-time lows after saying it suffered <a href=\"https://seekingalpha.com/pr/17714133-aqua-metals-suffers-significant-fire-damage\" target=\"_blank\">\"significant\" damage</a> from a Friday fire at its battery processing plant in Nevada.</li><li>AQMS says it expects to \"incur a material cost and experience a material delay in operating any processes within the plant,\" and is not yet able to provide specific information on a timeline.</li><li>The cause of the fire is not yet known.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522980\" data-linked=\"Aqua Metals&#39; battery processing plant ravaged by fire\" data-tweet=\"$AQMS - Aqua Metals&#39; battery processing plant ravaged by fire https://seekingalpha.com/news/3522980-aqua-metals-battery-processing-plant-ravaged-fire?source=tweet\" data-url=\"https://seekingalpha.com/news/3522980-aqua-metals-battery-processing-plant-ravaged-fire\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522955\" data-ts=\"1575302772\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLE\" target=\"_blank\">XLE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522955-crude-oil-energy-names-jump-on-talk-of-opec-supply-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude oil, energy names jump on talk of further OPEC supply cuts</a></h4><ul><li>The S&amp;P energy sector (<a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a> <font color=\"green\">+0.3%</font>) is <a href=\"https://www.cnbc.com/2019/12/02/oil-markets-china-economy-opec-in-focus.html\" target=\"_blank\">bucking the downward slide</a> in the broader market as January WTI crude oil <font color=\"green\">+1.6%</font> to $56.05/bbl, topping its 50-day moving average of $55.59/bbl.</li><li>The sector is rebounding from last week's 1.6% loss while the S&amp;P 500 rose 1% to a new all-time high.</li><li>Crude's spike comes after the release of better than expected manufacturing PMI readings from China but has eased off earlier highs after the U.S. ISM manufacturing PMI for November <a href=\"https://seekingalpha.com/news/3522927-ism-manufacturing-misses-estimates\" target=\"_blank\">came in below expectations</a>.</li><li>Also, Saudi Arabia reportedly will <a href=\"https://seekingalpha.com/news/3522813-oil-advances-talk-supply-cut-extension\" target=\"_blank\">push to extend production cuts</a> to at least June 2020 at this week's OPEC meeting.</li><li>Five of the top six gainers on the S&amp;P 500 are oil and gas names: <a href='https://seekingalpha.com/symbol/MRO' title='Marathon Oil Corporation'>MRO</a> <font color=\"green\">+2.7%</font>, <a href='https://seekingalpha.com/symbol/XEC' title='Cimarex Energy Co.'>XEC</a> <font color=\"green\">+2.2%</font>, <a href='https://seekingalpha.com/symbol/HFC' title='HollyFrontier Corporation'>HFC</a> <font color=\"green\">+1.9%</font>, <a href='https://seekingalpha.com/symbol/HP' title='Helmerich & Payne, Inc.'>HP</a> <font color=\"green\">+1.9%</font>, <a href='https://seekingalpha.com/symbol/NOV' title='National Oilwell Varco, Inc.'>NOV</a> <font color=\"green\">+1.8%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P GSCI Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3x Long Crude Oil ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Trust II - ProShares Ultra Bloomberg Crude Oil'>UCO</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/BNO' title='United States Brent Oil Fund, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity Covington Trust - Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/OILU' title='ProShares Trust II - ProShares UltraPro 3x Crude Oil ETF'>OILU</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/USL' title='United States 12 Month Oil Fund, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/USOU' title='USCF Funds Trust - United States 3x Oil Fund'>USOU</a>, <a href='https://seekingalpha.com/symbol/OILD' title='ProShares Trust II - ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3522955\" data-linked=\"Crude oil, energy names jump on talk of further OPEC supply cuts\" data-tweet=\"$XLE $MRO $XEC - Crude oil, energy names jump on talk of further OPEC supply cuts https://seekingalpha.com/news/3522955-crude-oil-energy-names-jump-on-talk-of-opec-supply-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/3522955-crude-oil-energy-names-jump-on-talk-of-opec-supply-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522953\" data-ts=\"1575302484\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522953-healthcare-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers</a></h4><ul><li><b>Gainers: </b>Kodiak Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/KOD' title='Kodiak Sciences Inc.'>KOD</a>) <font color=\"green\">+89%</font>. ASLAN Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ASLN' title='ASLAN Pharmaceuticals Limited'>ASLN</a>) <font color=\"green\">+63%</font>. PDS Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/PDSB' title='PDS Biotechnology Corporation'>PDSB</a>) <font color=\"green\">+21%</font>. Aquestive Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AQST' title='Aquestive Therapeutics, Inc.'>AQST</a>) <font color=\"green\">+16%</font>. Cortexyme (NASDAQ:<a href='https://seekingalpha.com/symbol/CRTX' title='Cortexyme, Inc.'>CRTX</a>) <font color=\"green\">+16%</font>.</li><li><b>Losers: </b>AgeX Therapeutics (NYSEMKT:<a href='https://seekingalpha.com/symbol/AGE' title='AgeX Therapeutics, Inc.'>AGE</a>) <font color=\"red\">-14%</font>. ObsEva (NASDAQ:<a href='https://seekingalpha.com/symbol/OBSV' title='ObsEva SA'>OBSV</a>) <font color=\"red\">-14%</font>. Aethlon Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/AEMD' title='Aethlon Medical, Inc.'>AEMD</a>) <font color=\"red\">-13%</font>. Akers Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/AKER' title='Akers Biosciences, Inc.'>AKER</a>) <font color=\"red\">-13%</font>. Hepion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/HEPA' title='Hepion Pharmaceuticals, Inc.'>HEPA</a>) <font color=\"red\">-12%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522953\" data-linked=\"Healthcare - Top 5 Gainers / Losers\" data-tweet=\"$KOD $ASLN $PDSB - Healthcare - Top 5 Gainers / Losers https://seekingalpha.com/news/3522953-healthcare-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3522953-healthcare-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522952\" data-ts=\"1575302465\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522952-china-dec-15-deadline-wilbur-ross\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China has Dec. 15 deadline - Wilbur Ross</a></h4><ul><li>Appearing on Fox Business, Commerce chief Wilbur Ross says if an agreement isn't in place by mid-month, the president has made clear he will boost tariffs on Chinese imports.</li><li>Stocks already opened lower after Trump announced the resumption of tariffs on Brazil and Argentina. They've added a bit to those losses since the Ross comments.</li><li>The S&amp;P 500 is <font color=\"red\">down 0.8%</font>, and the Nasdaq <font color=\"red\">1.35%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522952\" data-linked=\"China has Dec. 15 deadline - Wilbur Ross\" data-tweet=\"China has Dec. 15 deadline - Wilbur Ross https://seekingalpha.com/news/3522952-china-dec-15-deadline-wilbur-ross?source=tweet\" data-url=\"https://seekingalpha.com/news/3522952-china-dec-15-deadline-wilbur-ross\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>227&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522945\" data-ts=\"1575301193\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BYND\" target=\"_blank\">BYND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522945-beyond-meatminus-6-in-notable-reversal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Beyond Meat -6% in notable reversal</a></h4><ul> <li>Beyond Meat (NASDAQ:<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a>) is down sharply on heavy volume to all but erase last week's rally. There isn't any specific analyst ratings cut or corporate news to account for the weakened sentiment.</li> <li>Volume on Beyond Meat is already over 3.1M shares just an hour into the session.</li> <li>BYND is <font color=\"red\">off 6.09%</font> to $77.91 vs. the 52-week trading range of $25.00 to $239.71.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3522945\" data-linked=\"Beyond Meat -6% in notable reversal\" data-tweet=\"$BYND - Beyond Meat -6% in notable reversal https://seekingalpha.com/news/3522945-beyond-meatminus-6-in-notable-reversal?source=tweet\" data-url=\"https://seekingalpha.com/news/3522945-beyond-meatminus-6-in-notable-reversal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522944\" data-ts=\"1575301160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DXCM\" target=\"_blank\">DXCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522944-dexcom-down-2-on-g6-app-glitches\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DexCom down 2% on G6 app glitches</a></h4><ul><li>The broad market's selloff notwithstanding, DexCom (<a href='https://seekingalpha.com/symbol/DXCM' title='DexCom, Inc.'>DXCM</a> <font color=\"red\">-2.2%</font>) slips on below-average volume in early trade. Canaccord's Kyle Rose says the company experienced \"technical issues\" with its remote monitoring feature within the G6 app over the weekend, adding that the problems should not be a long-term concern for the company, \"at least not yet.\"</li><li>The stock was due for some sort of pullback considering its <font color=\"green\">48%</font> gallop since early November after its <a href=\"https://seekingalpha.com/news/3515879-dexcom-q3-sensor-sales-64-percent-shares-15-percent-hours\" target=\"_blank\">Q3 beat</a>.</li><li><strong>Update</strong>: The WSJ <a href=\"https://www.wsj.com/articles/diabetes-patients-blood-sugar-data-arent-being-shared-11575236392?mod=e2tw\" target=\"_blank\">reports </a>that parents of young children using the G6 monitor stated that blood sugar readings have not been able to be shared remotely since early Saturday (the monitor's communication with the patient's smartphone or datareader is unaffected). CEO Kevin Sayer will issue an update when more information is available.</li><li><strong>Update</strong>: On December 4, the WSJ <a href=\"https://www.wsj.com/articles/dexcoms-blood-sugar-monitor-data-sharing-returns-after-outage-11575495535?mod=pls_whats_news_us_business_f\" target=\"_blank\">reported </a>that the sharing feature is, again, up and running.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522944\" data-linked=\"DexCom down 2% on G6 app glitches\" data-tweet=\"$DXCM - DexCom down 2% on G6 app glitches https://seekingalpha.com/news/3522944-dexcom-down-2-on-g6-app-glitches?source=tweet\" data-url=\"https://seekingalpha.com/news/3522944-dexcom-down-2-on-g6-app-glitches\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522943\" data-ts=\"1575300691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRKS\" target=\"_blank\">BRKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522943-brooks-drops-after-10-k-filing-delay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brooks drops after 10-K filing delay</a></h4><ul><li>In a filing, Brooks Automation (<a href='https://seekingalpha.com/symbol/BRKS' title='Brooks Automation, Inc.'>BRKS</a> <font color='red'>-5.1%</font>) <a href=\"https://seekingalpha.com/filing/4720700\" target=\"_blank\">reveals</a> it isn't able to submit its 10-K within the prescribed time period. The company expects to file within the 15-day extension period.</li><li>Brooks says management is reviewing the timing of revenue recognition related to a product shipped from a Semiconductor Solutions Group contract manufacturer, which represents about $1M in revenue. Management and the board Audit Committee are also looking into the recognition timing of similar transactions.</li><li>In the 10-K, Brooks expects to report management's conclusion of a material weakness in internal controls related to revenue recorded as a business unit within the Brooks Life Sciences segment.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522943\" data-linked=\"Brooks drops after 10-K filing delay\" data-tweet=\"$BRKS - Brooks drops after 10-K filing delay https://seekingalpha.com/news/3522943-brooks-drops-after-10-k-filing-delay?source=tweet\" data-url=\"https://seekingalpha.com/news/3522943-brooks-drops-after-10-k-filing-delay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522940\" data-ts=\"1575300132\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YNDX\" target=\"_blank\">YNDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522940-yandex-governance-plan-iss-support\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yandex governance plan has ISS support</a></h4><ul>   <li>Yandex (<a href=\"http://seekingalpha.com/symbol/YNDX\" target=\"_blank\">YNDX</a> <font color=\"red\">-2.3%</font>) has won support from influential proxy adviser Institutional Shareholder Services for its plan to form its public interest foundation.</li>    <li>The company's board had <a href=\"https://yandex.com/company/press_center/press_releases/2019/2019-11-18-1\" target=\"_blank\">recommended the foundation</a> among targeted amendments to its governance structure in November.</li>    <li>That PIF would have no economic rights but hold limited governance rights; it would take over the company's Priority Share (currently held by Sberbank) and then be able to block the accumulation by a single entity of shares making up a 10% interest (down from the current threshold of 25%).</li>    <li>The PIF could also make binding nominations of two directors on the 12-person board.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3522940\" data-linked=\"Yandex governance plan has ISS support\" data-tweet=\"$YNDX - Yandex governance plan has ISS support https://seekingalpha.com/news/3522940-yandex-governance-plan-iss-support?source=tweet\" data-url=\"https://seekingalpha.com/news/3522940-yandex-governance-plan-iss-support\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522939\" data-ts=\"1575299991\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDR\" target=\"_blank\">MDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522939-mcdermott-gets-access-to-financing-reaches-forbearance-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McDermott gets access to financing, reaches forbearance agreement</a></h4><ul><li>McDermott (<a href='https://seekingalpha.com/symbol/MDR' title='McDermott International, Inc.'>MDR</a> <font color='green'>+8.5%</font>) says it has been <a href=\"https://seekingalpha.com/pr/17714755-mcdermott-access-350-million-tranche-b-financing-superpriority-senior-secured-credit-facility\" target=\"_blank\">granted access to $350M in financing</a> and reached a forbearance agreement with some of its creditors.</li><li>MDR says the second tranche of the $1.7B superpriority senior secured credit facility <a href=\"https://seekingalpha.com/news/3507173-mcdermott-wins-1_7b-new-financing\" target=\"_blank\">announced on Oct. 21</a>, which provides the company with a $250M term loan facility and a $100M letter of credit facility, should allow it to continue discussions regarding a long-term balance sheet solution.</li><li>Under terms of the forbearance agreement, holders of more than 35% of MDR's 10.625% senior notes due 2024 agree not to exercise their rights to the interest payment that was due on Nov. 1, 2019, and extends the agreement through Jan. 15, 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522939\" data-linked=\"McDermott gets access to financing, reaches forbearance agreement\" data-tweet=\"$MDR - McDermott gets access to financing, reaches forbearance agreement https://seekingalpha.com/news/3522939-mcdermott-gets-access-to-financing-reaches-forbearance-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3522939-mcdermott-gets-access-to-financing-reaches-forbearance-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>225&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522936\" data-ts=\"1575299869\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RTIX\" target=\"_blank\">RTIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522936-fda-clears-rti-surgicals-streamline-mis-spinal-fixation-system\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA clears RTI Surgical&#39;s Streamline MIS Spinal Fixation System</a></h4><ul><li>The FDA <a href=\"https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K192396\" target=\"_blank\">grants 501(k) clearance</a> to RTI Surgical's (<a href='https://seekingalpha.com/symbol/RTIX' title='RTI Surgical Holdings, Inc.'>RTIX</a> <font color=\"green\">+3.2%</font>) <a href=\"http://www.rtix.com/en_us/products/product-implant/streamline-mis-spinal-fixation-system\" target=\"_blank\">Streamline MIS Spinal Fixation System</a> used to create a rigid construct in the thoracolumbar spine (thoracic and lumbar regions) via a percutaneous or mini-open approach.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522936\" data-linked=\"FDA clears RTI Surgical&#39;s Streamline MIS Spinal Fixation System\" data-tweet=\"$RTIX - FDA clears RTI Surgical&#39;s Streamline MIS Spinal Fixation System https://seekingalpha.com/news/3522936-fda-clears-rti-surgicals-streamline-mis-spinal-fixation-system?source=tweet\" data-url=\"https://seekingalpha.com/news/3522936-fda-clears-rti-surgicals-streamline-mis-spinal-fixation-system\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522930\" data-ts=\"1575299235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEVO\" target=\"_blank\">GEVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522930-bombardier-uses-gevos-sustainable-aviation-fuel-for-new-aircraft-deliveries\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bombardier uses Gevo&#39;s sustainable aviation fuel for new aircraft deliveries</a></h4><ul><li>Gevo (<a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='green'>+3.9%</font>) pops at the open after starting <a href=\"https://seekingalpha.com/pr/17714852-bombardier-adopts-gevo-s-sustainable-aviation-fuel-new-aircraft-deliveries-canada\" target=\"_blank\">delivery of its sustainable aviation fuel</a> to Bombardier (<a href='https://seekingalpha.com/symbol/BDRBF' title='Bombardier Inc.'>OTCQX:BDRBF</a>) for new customer aircraft deliveries in Canada.</li><li>Bombardier says the delivery is the <a href=\"https://biofuels-news.com/news/bombardier-receives-first-shipment-of-sustainable-aviation-fuel-in-canada/\" target=\"_blank\">first step in its plan</a> to secure long-term  partnerships with fuel suppliers to deploy sustainable aviation fuel to all of its facilities.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522930\" data-linked=\"Bombardier uses Gevo&#39;s sustainable aviation fuel for new aircraft deliveries\" data-tweet=\"$GEVO $BDRBF $BDRAF - Bombardier uses Gevo&#39;s sustainable aviation fuel for new aircraft deliveries https://seekingalpha.com/news/3522930-bombardier-uses-gevos-sustainable-aviation-fuel-for-new-aircraft-deliveries?source=tweet\" data-url=\"https://seekingalpha.com/news/3522930-bombardier-uses-gevos-sustainable-aviation-fuel-for-new-aircraft-deliveries\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522929\" data-ts=\"1575299089\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FGEN\" target=\"_blank\">FGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522929-fibrogen-up-3-on-reimbursement-of-roxadustat-in-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FibroGen up 3% on reimbursement of roxadustat in China</a></h4><ul><li>China's National Healthcare Security Administration has <a href=\"https://seekingalpha.com/pr/17714376-fibrogen-announces-roxadustat-inclusion-china-s-national-reimbursement-drug-list\" target=\"_blank\">added</a> FibroGen's (<a href='https://seekingalpha.com/symbol/FGEN' title='FibroGen, Inc.'>FGEN</a> <font color=\"green\">+2.9%</font>) roxadustat to its National Reimbursement Drug List for the treatment of anemia in chronic kidney disease patients, both dialysis-dependent and non-dialysis-dependent.</li><li>The company is collaborating with AstraZeneca (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca PLC'>AZN</a> <font color=\"red\">-0.1%</font>) on development and commercialization there.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522929\" data-linked=\"FibroGen up 3% on reimbursement of roxadustat in China\" data-tweet=\"$FGEN $AZN - FibroGen up 3% on reimbursement of roxadustat in China https://seekingalpha.com/news/3522929-fibrogen-up-3-on-reimbursement-of-roxadustat-in-china?source=tweet\" data-url=\"https://seekingalpha.com/news/3522929-fibrogen-up-3-on-reimbursement-of-roxadustat-in-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522923\" data-ts=\"1575298092\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OLLI\" target=\"_blank\">OLLI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522923-ollies-bargain-outletminus-8-after-ceo-dies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ollie&#39;s Bargain Outlet -8% after CEO dies</a></h4><ul> <li>Ollie's Bargain Outlet Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/OLLI' title='Ollie&#39;s Bargain Outlet Holdings, Inc.'>OLLI</a>) falls sharply after the company announces the unexpected death of Chairman/CEO Mark Butler over the Thanksgiving weekend.</li>  <li>The board of directors has named COO John Swygert as interim president and CEO.</li><li>Ollie's is <font color=\"red\">down 8.40%</font> on the day to trade at its lowest level in about two months.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17714894-ollie-s-bargain-outlet-announces-unexpected-passing-chairman-board-president-ceo-mark-butler\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3522923\" data-linked=\"Ollie&#39;s Bargain Outlet -8% after CEO dies\" data-tweet=\"$OLLI - Ollie&#39;s Bargain Outlet -8% after CEO dies https://seekingalpha.com/news/3522923-ollies-bargain-outletminus-8-after-ceo-dies?source=tweet\" data-url=\"https://seekingalpha.com/news/3522923-ollies-bargain-outletminus-8-after-ceo-dies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522919\" data-ts=\"1575297776\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALEAF\" target=\"_blank\">ALEAF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522919-aleafia-up-4-on-7m-cannabis-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aleafia up 4% on $7M cannabis sale</a></h4><ul><li>Aleafia Health (<a href='https://seekingalpha.com/symbol/ALEAF' title='Aleafia Health Inc.'>OTCQX:ALEAF</a>) is up <font color=\"green\">4%</font> in early trade in response to an <a href=\"https://seekingalpha.com/pr/17714411-aleafia-health-completes-7_1m-cannabis-sale-agreement\" target=\"_blank\">order </a>from a licensed producer in Canada for 2,840 kg of dried cannabis flower at $2.50 per gram for a total of $7.1M. The transaction, consisting of three shipments, will be completed before the end of next month.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522919\" data-linked=\"Aleafia up 4% on $7M cannabis sale\" data-tweet=\"$ALEAF - Aleafia up 4% on $7M cannabis sale https://seekingalpha.com/news/3522919-aleafia-up-4-on-7m-cannabis-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3522919-aleafia-up-4-on-7m-cannabis-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522907\" data-ts=\"1575296565\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522907-skt-clvs-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SKT, CLVS among premarket gainers</a></h4><ul><li>ASLAN Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ASLN' title='ASLAN Pharmaceuticals Limited'>ASLN</a>) <font color=\"green\">+85%</font> on <a href=\"https://seekingalpha.com/news/3522830-aslan-pharma-85-percent-premarket-positive-aslan004-data\" target=\"_blank\">positive</a> ASLAN004 data.</li><li>Akari Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics, Plc'>AKTX</a>) <font color=\"green\">+38%</font> on <a href=\"https://seekingalpha.com/pr/17714693-akari-therapeutics-announces-pivotal-phase-iii-trial-design-nomacopan-pediatric-hematopoietic\" target=\"_blank\">announcing</a> pivotal phase III trial design of Nomacopan in pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy, following FDA meeting.</li><li>Evofem Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/EVFM' title='Evofem Biosciences, Inc.'>EVFM</a>) <font color=\"green\">+23%</font> on <a href=\"https://seekingalpha.com/news/3522856-evofem-24-percent-premarket-positive-amphora-data-std-prevention\" target=\"_blank\">positive</a> Amphora data in STD prevention.</li><li>NF Energy Saving (NASDAQ:<a href='https://seekingalpha.com/symbol/BIMI' title='NF Energy Saving Corporation'>BIMI</a>) <font color=\"green\">+16%</font> on <a href=\"https://seekingalpha.com/pr/17714678-nf-energy-saving-corporation-enters-mou-acquire-chongqing-guanzan-technology\" target=\"_blank\">acquiring</a> Chongqing Guanzan Technology Co., Ltd.</li><li>Xenon Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/XENE' title='Xenon Pharmaceuticals Inc.'>XENE</a>) <font color=\"green\">+16%</font> on Neurocrine Bio <a href=\"https://seekingalpha.com/news/3522869-xenon-pharma-23-percent-premarket-neurocrine-bio-partnership-epilepsy\" target=\"_blank\">partnership</a> in epilepsy.</li><li>Oramed Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ORMP' title='Oramed Pharmaceuticals Inc.'>ORMP</a>) <font color=\"green\">+15%</font>.</li><li>Cassava Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SAVA' title='Cassava Sciences, Inc.'>SAVA</a>) <font color=\"green\">+12%</font>.</li><li>Aquestive Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AQST' title='Aquestive Therapeutics, Inc.'>AQST</a>) <font color=\"green\">+9%</font> on <a href=\"https://seekingalpha.com/news/3522871-aquestive-plus-8-percent-premarket-completing-nda-submission-libervant-buccal-film\" target=\"_blank\">completing</a> NDA submission for libervant buccal film.</li><li>Karyopharm Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/KPTI' title='Karyopharm Therapeutics Inc.'>KPTI</a>) <font color=\"green\">+7%</font>.</li><li>AMERI Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRH' title='AMERI Holdings, Inc.'>AMRH</a>) <font color=\"green\">+5%</font> on <a href=\"https://seekingalpha.com/pr/17714542-ameri100-lands-another-sap-s-4hana-project-kingdom-saudi-arabia\" target=\"_blank\">another SAP S/4HANA project</a> in the Kingdom of Saudi Arabia.</li><li>Tanger Factory Outlet Centers (NYSE:<a href='https://seekingalpha.com/symbol/SKT' title='Tanger Factory Outlet Centers, Inc.'>SKT</a>) <font color=\"green\">+6%</font>.</li><li>Pintec Technology Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PT' title='Pintec Technology Holdings Limited'>PT</a>) <font color=\"green\">+5%</font>.</li><li>Clovis Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology, Inc.'>CLVS</a>) <font color=\"green\">+5%</font>.</li><li>Hepion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/HEPA' title='Hepion Pharmaceuticals, Inc.'>HEPA</a>) <font color=\"green\">+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522907\" data-linked=\"SKT, CLVS among premarket gainers\" data-tweet=\"$ASLN $AKTX $EVFM - SKT, CLVS among premarket gainers https://seekingalpha.com/news/3522907-skt-clvs-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3522907-skt-clvs-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522906\" data-ts=\"1575296548\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKTX\" target=\"_blank\">AKTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522906-akari-up-28-premarket-on-advancement-of-nomacopan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akari up 28% premarket on advancement of nomacopan</a></h4><ul><li>Thinly traded nano cap Akari Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics, Plc'>AKTX</a>) is up <font color=\"green\">28% </font>premarket on robust volume on the heels of its design of a two-part Phase 3 clinical trial evaluating Coversin (nomacopan) in pediatric patients hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA), an Orphan Drug- and Fast Track-tagged indication.</li><li>Part A will confirm the dosing scheme while Part B will assess the efficacy of the confirmed dosing regimen.</li><li>The trial should commence this month.</li><li>Concurrently, the company <a href=\"https://seekingalpha.com/pr/17714693-akari-therapeutics-announces-pivotal-phase-iii-trial-design-nomacopan-pediatric-hematopoietic\" target=\"_blank\">announced </a>results on six paroxysmal nocturnal hemoglobinuria &#40;PNH&#41; patients receiving nomacopan in a long-term Phase 2 study. All are transfusion-independent after being transfusion-dependent at entry.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522906\" data-linked=\"Akari up 28% premarket on advancement of nomacopan\" data-tweet=\"$AKTX - Akari up 28% premarket on advancement of nomacopan https://seekingalpha.com/news/3522906-akari-up-28-premarket-on-advancement-of-nomacopan?source=tweet\" data-url=\"https://seekingalpha.com/news/3522906-akari-up-28-premarket-on-advancement-of-nomacopan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522905\" data-ts=\"1575296500\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522905-morgan-stanley-resets-neutral-stance-on-chinese-online-firms\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley resets Neutral stance on Chinese online firms</a></h4><ul>   <li>Morgan Stanley has gone Neutral on a number of Chinese communications services names, meaning upgrades for some and cuts for others.</li>    <li>Changyou.com (NASDAQ:<a href='https://seekingalpha.com/symbol/CYOU' title='Changyou.com Limited'>CYOU</a>) is <font color=\"green\">up 2.6%</font> premarket in U.S. trading after the firm raised it to Equal Weight. It set its price target on the ADRs to $10, implying 4.7% upside.</li>    <li>Meanwhile it's started coverage of iQiyi (NASDAQ:<a href='https://seekingalpha.com/symbol/IQ' title='iQIYI, Inc.'>IQ</a>) at Equal Weight, warning of tapering growth in Chinese online video coming alongside \"lukewarm\" ad demand in the near term. It has a $20 price target vs. a current $19.15; shares are <font color=\"red\">down 0.4%</font> premarket.</li>    <li>And Huya (NYSE:<a href='https://seekingalpha.com/symbol/HUYA' title='HUYA Inc.'>HUYA</a>) is <font color=\"red\">down 1.5%</font> premarket after getting cut to Equal Weight from Overweight. A price target of $23 on the ADRs implies 9% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3522905\" data-linked=\"Morgan Stanley resets Neutral stance on Chinese online firms\" data-tweet=\"$CYOU $IQ $HUYA - Morgan Stanley resets Neutral stance on Chinese online firms https://seekingalpha.com/news/3522905-morgan-stanley-resets-neutral-stance-on-chinese-online-firms?source=tweet\" data-url=\"https://seekingalpha.com/news/3522905-morgan-stanley-resets-neutral-stance-on-chinese-online-firms\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522901\" data-ts=\"1575296003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522901-lxrx-apa-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LXRX, APA among premarket losers</a></h4><ul><li>Aqua Metals (NASDAQ:<a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals, Inc.'>AQMS</a>) <font color=\"red\">-41%</font> after <a href=\"https://seekingalpha.com/pr/17714133-aqua-metals-suffers-significant-fire-damage\" target=\"_blank\">fire broke out</a> at the plant.</li><li>Lexicon Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a>) <font color=\"red\">-21%</font> on <a href=\"https://seekingalpha.com/news/3522852-lexicon-loses-appeal-sotagliflozin-crl-shares-10-percent-premarket\" target=\"_blank\">losing appeal</a> of sotagliflozin CRL.</li><li>Paringa Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/PNRL' title='Paringa Resources Limited'>PNRL</a>) <font color=\"red\">-13%</font>.</li><li>Can-Fite BioPharma (NYSEMKT:<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite BioPharma Ltd.'>CANF</a>) <font color=\"red\">-11%</font>.</li><li>Apache (NYSE:<a href='https://seekingalpha.com/symbol/APA' title='Apache Corporation'>APA</a>) <font color=\"red\">-10%</font> on issuing operational update on the <a href=\"https://seekingalpha.com/news/3522878-apache-drill-deeper-first-suriname-well\" target=\"_blank\">Maka Central - 1 well offshore Suriname</a>.</li><li>Roku (NASDAQ:<a href='https://seekingalpha.com/symbol/ROKU' title='Roku, Inc.'>ROKU</a>) <font color=\"red\">-8%</font> on <a href=\"https://seekingalpha.com/news/3522877-morgan-stanley-bearish-roku-valuation-shares-minus-7_5-percent\" target=\"_blank\">analyst downgrade</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3522901\" data-linked=\"LXRX, APA among premarket losers\" data-tweet=\"$AQMS $LXRX $PNRL - LXRX, APA among premarket losers https://seekingalpha.com/news/3522901-lxrx-apa-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3522901-lxrx-apa-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522891\" data-ts=\"1575295176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522891-goldman-neutral-on-bausch-health-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman neutral on Bausch Health in premarket analyst action</a></h4><ul><li>Bausch Health Companies (NYSE:<a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a>) initiated with Neutral rating and C$40 (7% upside) price target at Goldman Sachs. Shares up <font color=\"green\">2%</font> premarket.</li><li>Centogene N.V. (NASDAQ:<a href='https://seekingalpha.com/symbol/CNTG' title='Centogene N.V.'>CNTG</a>) initiated with Buy rating and $18 (38% upside) price target at BTIG Research. Initiated with Outperform rating and $17 target at Evercore ISI.</li><li>Galapagos N.V. (NASDAQ:<a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos NV'>GLPG</a>) initiated with Neutral rating and \u20ac199 (11% upside) price target at BofA Merrill Lynch.</li><li>Galera Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GRTX' title='Galera Therapeutics, Inc.'>GRTX</a>) initiated with Buy rating and $15 (20% upside) price target at BofAML. Initiated with Buy rating and $20 target at Citigroup. Shares up <font color=\"green\">1% </font>premarket.</li><li>Galmed Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a>) initiated with Buy rating and $29 (544% upside) price target at Canaccord Genuity. Shares up <font color=\"green\">16%</font> premarket.</li><li>GlaxoSmithKline (NYSE:<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline plc'>GSK</a>) initiated with Outperform rating and $53 (17% upside) price target at SVB Leerink. Shares down <font color=\"red\">1%</font> premarket.</li><li>Intercept Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals, Inc.'>ICPT</a>) initiated with Buy rating and $165 (52% upside) price target at Canaccord.</li><li>Revance Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RVNC' title='Revance Therapeutics, Inc.'>RVNC</a>) initiated with Buy rating and $25 (40% upside) price target at Goldman.</li><li>TherapeuticsMD (NASDAQ:<a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD, Inc.'>TXMD</a>) initiated with Buy rating and $5 (99% upside) price target at Guggenheim. Shares up <font color=\"green\">3% </font>premarket.</li><li>Theratechnologies (NASDAQ:<a href='https://seekingalpha.com/symbol/THTX' title='Theratechnologies Inc.'>THTX</a>) initiated with Buy rating and $12 (280% upside) price target at Canaccord.</li><li>Trulieve Cannabis (TRUL CN)(<a href='https://seekingalpha.com/symbol/TCNNF' title='Trulieve Cannabis Corp.'>OTCPK:TCNNF</a>) upgraded to Buy with a C$22.60 (33% upside) price target at Compass Point.</li><li>Biogen (NASDAQ:<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a>) downgraded to Underperform with a $250 (17% downside risk) price target at Baird.</li><li>Teladoc (NYSE:<a href='https://seekingalpha.com/symbol/TDOC' title='Teladoc Health, Inc.'>TDOC</a>) downgraded to Hold with an $80 (4% downside risk) price target at SunTrust. Shares down <font color=\"red\">3% </font>premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522891\" data-linked=\"Goldman neutral on Bausch Health in premarket analyst action\" data-tweet=\"$BHC $CNTG $GLPG - Goldman neutral on Bausch Health in premarket analyst action https://seekingalpha.com/news/3522891-goldman-neutral-on-bausch-health-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3522891-goldman-neutral-on-bausch-health-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522884\" data-ts=\"1575293837\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522884-walgreens-buyout-stalls-expected\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Walgreens buyout stalls as expected</a></h4><ul> <li>The private equity buyout of Walgreens Boots Alliance (NASDAQ:<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a>) is reportedly in trouble as financing issue arise for KKR (NYSE:<a href='https://seekingalpha.com/symbol/KKR' title='KKR & Co. Inc.'>KKR</a>) just as many analysts anticipated.</li> <li>Speed bumps with leveraged buyouts are nothing <a href=\"https://www.wsj.com/articles/private-equity-cash-piles-up-as-takeover-targets-get-pricier-11575208800\" target=\"_blank\">new</a> this year, according to <em>The Wall Street Journal</em>. Buyout activity in the U.S. is down sharply, despite PE firms sitting on a record amount of cash.</li> <li>WBA <font color=\"red\">-0.35%</font> premarket to $59.60.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3522884\" data-linked=\"Walgreens buyout stalls as expected\" data-tweet=\"$WBA $KKR - Walgreens buyout stalls as expected https://seekingalpha.com/news/3522884-walgreens-buyout-stalls-expected?source=tweet\" data-url=\"https://seekingalpha.com/news/3522884-walgreens-buyout-stalls-expected\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522880\" data-ts=\"1575293112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVAV\" target=\"_blank\">AVAV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522880-aerovironment-lands-street-high-pt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AeroVironment lands Street-high PT</a></h4><ul><li>AeroVironment (NASDAQ:<a href='https://seekingalpha.com/symbol/AVAV' title='AeroVironment, Inc.'>AVAV</a>) has been upgraded to Outperform from Neutral at Baird ahead of the company's Q2 results tomorrow. PT was raised to a Street-high view of $81 from $65.</li><li>Analyst Peter Arment expects a \"solid\" report, while the FY20 outlook \"should be at least maintained with potential for upside\" given international growth.</li><li>AVAV <font color=\"green\">+5.3%</font> premarket</li><li>Source: Bloomberg First Word</li></ul><div class=\"tiny-share-widget\" data-id=\"3522880\" data-linked=\"AeroVironment lands Street-high PT\" data-tweet=\"$AVAV - AeroVironment lands Street-high PT https://seekingalpha.com/news/3522880-aerovironment-lands-street-high-pt?source=tweet\" data-url=\"https://seekingalpha.com/news/3522880-aerovironment-lands-street-high-pt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522878\" data-ts=\"1575292984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APA\" target=\"_blank\">APA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522878-apache-to-drill-deeper-first-suriname-well\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apache to drill deeper at first Suriname well</a></h4><ul><li>Apache (NYSE:<a href='https://seekingalpha.com/symbol/APA' title='Apache Corporation'>APA</a>) <font color=\"red\">-9.5%</font> pre-market following a disappointing <a href=\"https://seekingalpha.com/pr/17714407-apache-corporation-issues-operational-update-maka-central-1-well-offshore-suriname\" target=\"_blank\">operational update</a> on its Maka Central-1 well offshore Suriname with no reported hydrocarbon finds or initial well tests.</li><li>Upon reaching a depth of 6,200 meters, APA says it decided  to conduct various testing activities in two distinct Upper Cretaceous  play types; following completion of these tests, the company will  set casing, make equipment modifications to the rig, and resume drilling  in mid-December to evaluate a third play type in the Cretaceous, with a new target depth of 6,900 meters.</li><li>The well is APA's first of three committed wells in Block 58 offshore Suriname.</li><li>APA's Suriname drilling effort is just seven miles from the Guyana maritime border, and the company is <a href=\"https://www.chron.com/business/energy/article/Apache-reports-muted-first-results-in-Suriname-14875172.php\" target=\"_blank\">hoping to replicate Exxon's success</a> in finding oil in the area.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522878\" data-linked=\"Apache to drill deeper at first Suriname well\" data-tweet=\"$APA - Apache to drill deeper at first Suriname well https://seekingalpha.com/news/3522878-apache-to-drill-deeper-first-suriname-well?source=tweet\" data-url=\"https://seekingalpha.com/news/3522878-apache-to-drill-deeper-first-suriname-well\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>83&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522877\" data-ts=\"1575292857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKU\" target=\"_blank\">ROKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522877-morgan-stanley-bearish-on-roku-valuation-sharesminus-7_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley bearish on Roku valuation; shares -7.5%</a></h4><ul><li>Morgan Stanley downgrades Roku (NASDAQ:<a href='https://seekingalpha.com/symbol/ROKU' title='Roku, Inc.'>ROKU</a>) from Equal-Weight to Underweight and raises the target by $10 to $110.</li><li>Analyst Benjamin Swinburne thinks revenue and gross profit growth could \"slow meaningfully\" next year.</li><li>Shares are up over 400% in 2019, which skews the risk profile \"to the downside.\"</li><li>The analyst says valuation has \"surged past digital media players and even past high-growth\" SaaS companies despite ROKU's lower gross margins.</li><li>Roku shares are <font color=\"red\">down 7.5%</font> pre-market to $148.31.</li><li>ROKU has a Bullish average <a href=\"https://seekingalpha.com/symbol/ROKU/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522877\" data-linked=\"Morgan Stanley bearish on Roku valuation; shares -7.5%\" data-tweet=\"$ROKU - Morgan Stanley bearish on Roku valuation; shares -7.5% https://seekingalpha.com/news/3522877-morgan-stanley-bearish-on-roku-valuation-sharesminus-7_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3522877-morgan-stanley-bearish-on-roku-valuation-sharesminus-7_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>122&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522873\" data-ts=\"1575292493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522873-citi-picks-altria-over-philip-morris\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi picks Altria over Philip Morris</a></h4><ul> <li>Citi sees more upside for tobacco sector investors with Altria (NYSE:<a href='https://seekingalpha.com/symbol/MO' title='Altria Group, Inc.'>MO</a>) than Philip Morris International (NYSE:<a href='https://seekingalpha.com/symbol/PM' title='Philip Morris International Inc.'>PM</a>) based on current valuations on the two.</li> <li>The firm lifts Altria to a Buy rating from Neutral, while sliding Philip Morris to a Neutral rating from Buy.</li> <li>Shares of Altria are <font color=\"green\">up 0.52%</font> premarket to $49.89. Philip Morris is <font color=\"red\">down 0.55%</font> in the early session.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3522873\" data-linked=\"Citi picks Altria over Philip Morris\" data-tweet=\"$MO $PM - Citi picks Altria over Philip Morris https://seekingalpha.com/news/3522873-citi-picks-altria-over-philip-morris?source=tweet\" data-url=\"https://seekingalpha.com/news/3522873-citi-picks-altria-over-philip-morris\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>61&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522871\" data-ts=\"1575292359\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AQST\" target=\"_blank\">AQST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522871-aquestiveplus-8-premarket-on-completing-nda-submission-for-libervant-buccal-film\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aquestive +8% premarket on completing NDA submission for libervant buccal film</a></h4><ul> <li>Aquestive Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AQST' title='Aquestive Therapeutics, Inc.'>AQST</a>) <a href=\"https://seekingalpha.com/pr/17714449-aquestive-therapeutics-completes-rolling-submission-new-drug-application-nda-u-s-food-drug\" target=\"_blank\">completes</a> the rolling submission of a NDA to the FDA for its therapeutic candidate Libervant (diazepam) Buccal Film for the management of seizure clusters.</li>   <li>The company plans to share the results from the single dose crossover study at the upcoming American Epilepsy Society 2019 Annual Meeting.</li><li>Shares are up <font color=\"green\">8%</font> premarket.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3522871\" data-linked=\"Aquestive +8% premarket on completing NDA submission for libervant buccal film\" data-tweet=\"$AQST - Aquestive +8% premarket on completing NDA submission for libervant buccal film https://seekingalpha.com/news/3522871-aquestiveplus-8-premarket-on-completing-nda-submission-for-libervant-buccal-film?source=tweet\" data-url=\"https://seekingalpha.com/news/3522871-aquestiveplus-8-premarket-on-completing-nda-submission-for-libervant-buccal-film\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522869\" data-ts=\"1575292204\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XENE\" target=\"_blank\">XENE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522869-xenon-pharma-up-23-premarket-on-neurocrine-bio-partnership-in-epilepsy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xenon Pharma up 23% premarket on Neurocrine Bio partnership in epilepsy</a></h4><ul><li>Thinly traded micro cap Xenon Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/XENE' title='Xenon Pharmaceuticals Inc.'>XENE</a>) is up <font color=\"green\">23%</font> premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17714443-neurocrine-biosciences-xenon-pharmaceuticals-announce-agreement-develop-first-class\" target=\"_blank\">license and collaboration deal</a> with Neurocrine Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NBIX' title='Neurocrine Biosciences, Inc.'>NBIX</a>) to develop treatments for epilepsy.</li><li>Under the terms of the agreement, NBIX will have an exclusive license to XEN901 and certain preclinical candidates. The partnership also includes a multiyear research collaboration aimed at discovering and developing additional assets.</li><li>XENE will receive $30M upfront, a $20M equity investment from NBIX based on a share price of $14.196, a $25M milestone payment triggered by the FDA acceptance of the XEN901 IND (expected to be filed in mid-2020), up to $1.7B in additional milestones, low double-digit-to-mid-teen royalties on U.S. sales of XEN901 and slightly lower royalties on ex-U.S. sales of XEN901.</li><li>XENE will be eligible to receive tiered mid-single-digit-to-low double-digit royalties on U.S. sales of other products (slightly lower rates ex-U.S.).</li><li>The company will host a conference call this morning at 8:30 am ET to discuss the collaboration.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522869\" data-linked=\"Xenon Pharma up 23% premarket on Neurocrine Bio partnership in epilepsy\" data-tweet=\"$XENE $XENE $NBIX - Xenon Pharma up 23% premarket on Neurocrine Bio partnership in epilepsy https://seekingalpha.com/news/3522869-xenon-pharma-up-23-premarket-on-neurocrine-bio-partnership-in-epilepsy?source=tweet\" data-url=\"https://seekingalpha.com/news/3522869-xenon-pharma-up-23-premarket-on-neurocrine-bio-partnership-in-epilepsy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522865\" data-ts=\"1575291998\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPLK\" target=\"_blank\">SPLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522865-splunkplus-2-goldman-turns-bullish\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Splunk +2% as Goldman turns bullish</a></h4><ul><li>Splunk (NASDAQ:<a href='https://seekingalpha.com/symbol/SPLK' title='Splunk Inc.'>SPLK</a>) shares <font color=\"green\">gain 2.1%</font> pre-market to $152.31 after Goldman Sachs upgrades the company from Neutral to Buy.</li><li>Goldman sets the price target at $180, a 21% upside.</li><li>The firm cites the recent <a href=\"https://seekingalpha.com/news/3521346-splunk-beats-raises-fy-revenue-view-shares-plus-5_6-percent\" target=\"_blank\">Q3 report</a>, which included<a href=\"https://seekingalpha.com/news/3521564-splunk-targets-raised-cash-flow-forecast\" target=\"_blank\"> FCF guidance</a> that saw $1B in FY23.</li><li>Splunk has a Bullish average <a href=\"https://seekingalpha.com/symbol/SPLK\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522865\" data-linked=\"Splunk +2% as Goldman turns bullish\" data-tweet=\"$SPLK - Splunk +2% as Goldman turns bullish https://seekingalpha.com/news/3522865-splunkplus-2-goldman-turns-bullish?source=tweet\" data-url=\"https://seekingalpha.com/news/3522865-splunkplus-2-goldman-turns-bullish\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522856\" data-ts=\"1575291195\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVFM\" target=\"_blank\">EVFM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522856-evofem-up-24-premarket-on-positive-amphora-data-in-std-prevention\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evofem up 24% premarket on positive Amphora data in STD prevention</a></h4><ul><li>Thinly traded micro cap Evofem Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/EVFM' title='Evofem Biosciences, Inc.'>EVFM</a>) is up <font color=\"green\">24%</font> premarket on increased volume, albeit on turnover of only 84K shares, in response to <a href=\"https://seekingalpha.com/pr/17714316-evofem-biosciences-reports-positive-top-line-results-phase-2b-study-amphora-prevention\" target=\"_blank\">positive topline results</a> from a Phase 2b clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03107377?spons=evofem&amp;phase=1&amp;draw=2&amp;rank=1\" target=\"_blank\">AMPREVENCE</a>, evaluating Amphora (L-lactic acid, citric acid and potassium bitartrate) vaginal gel for the prevention of urogenital chlamydia and gonorrhea in women.</li><li>The study met the primary and secondary endpoints with a favorable safety profile.</li><li>Specifically, the chlamydia infection rate in the Amphora cohort was 4.9% (n=14/288) at month 4 compared to 9.8% (n=28/287) for placebo (p=0.024). The gonorrhea infection rate was 0.7% (n=2/280) versus 3.2% (n=9/277) for control (p=0.03).</li><li>The company intends to submit the data for presentation at a future medical conference.</li><li>An End-of-Phase 2 meeting with the FDA is next up.</li><li>Management will host a conference call this morning at 8:30 am ET to discuss the results.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522856\" data-linked=\"Evofem up 24% premarket on positive Amphora data in STD prevention\" data-tweet=\"$EVFM - Evofem up 24% premarket on positive Amphora data in STD prevention https://seekingalpha.com/news/3522856-evofem-up-24-premarket-on-positive-amphora-data-in-std-prevention?source=tweet\" data-url=\"https://seekingalpha.com/news/3522856-evofem-up-24-premarket-on-positive-amphora-data-in-std-prevention\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522852\" data-ts=\"1575290341\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LXRX\" target=\"_blank\">LXRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522852-lexicon-loses-appeal-of-sotagliflozin-crl-shares-down-10-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lexicon loses appeal of sotagliflozin CRL; shares down 10% premarket</a></h4><ul><li>The FDA has <a href=\"https://seekingalpha.com/pr/17714410-lexicon-pharmaceuticals-receives-formal-dispute-resolution-request-decision-fda-s-office-new\" target=\"_blank\">denied </a>Lexicon Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a>) appeal of the <a href=\"https://seekingalpha.com/news/3445177-lexicon-29-percent-fda-rejection-sotagliflozin\" target=\"_blank\">CRL it received in March</a> related to its marketing application for type 1 diabetes med sotagliflozin. Undeterred, it now plans to appeal the decision to the Center for Drug Evaluation and Research &#40;CDER&#41;.</li><li>The company will host a conference call this morning at 8:00 am ET to discuss the matter.</li><li>Shares down <font color=\"red\">10%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522852\" data-linked=\"Lexicon loses appeal of sotagliflozin CRL; shares down 10% premarket\" data-tweet=\"$LXRX - Lexicon loses appeal of sotagliflozin CRL; shares down 10% premarket https://seekingalpha.com/news/3522852-lexicon-loses-appeal-of-sotagliflozin-crl-shares-down-10-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3522852-lexicon-loses-appeal-of-sotagliflozin-crl-shares-down-10-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522851\" data-ts=\"1575290337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DE\" target=\"_blank\">DE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522851-bofa-merrill-sees-10-downside-for-deere\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofA/Merrill sees 10% downside for Deere</a></h4><ul><li>Deere (NYSE:<a href='https://seekingalpha.com/symbol/DE' title='Deere & Company'>DE</a>) <font color=\"red\">-1.1%</font> premarket after BofA/Merrill <a href=\"https://www.streetinsider.com/Downgrades/BofAMerrill+Lynch+Downgrades+Deere+%28DE%29+to+Underperform/16196666.html\" target=\"_blank\">downgraded</a> the stock to Underperform (from Neutral), with a $150 PT (10%+ downside).</li><li>Analyst Ross Gilardi see last week's lowered outlook as \"more realistic than conservative,\" while the agriculture setup for next year is very challenging.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522851\" data-linked=\"BofA/Merrill sees 10% downside for Deere\" data-tweet=\"$DE - BofA/Merrill sees 10% downside for Deere https://seekingalpha.com/news/3522851-bofa-merrill-sees-10-downside-for-deere?source=tweet\" data-url=\"https://seekingalpha.com/news/3522851-bofa-merrill-sees-10-downside-for-deere\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3522850\" data-ts=\"1575290097\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3522850-docu-target-raised-solid-q3-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DOCU target raised before &#39;solid&#39; Q3 report</a></h4><ul><li>DocuSign (NASDAQ:<a href='https://seekingalpha.com/symbol/DOCU' title='DocuSign, Inc.'>DOCU</a>) gets a target boost from $80 to $93 at RBC, which maintains an Outperform rating. The company has a Bullish average <a href=\"https://seekingalpha.com/symbol/DOCU/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>Analyst Alex Zukin cites conversations with DOCU management suggesting that Thursday's Q3 report will be \"solid\" as the company benefits \"from a continuation of favorable trends seen in 2Q.\"</li><li>The analyst expects strong customer activity in Q3 and that Adobe (NASDAQ:<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Inc.'>ADBE</a>) was \"modestly less competitive\" in the quarter.</li><li>DOCU shares are <font color=\"green\">up 2.2%</font> pre-market to $72.75.</li></ul><div class=\"tiny-share-widget\" data-id=\"3522850\" data-linked=\"DOCU target raised before &#39;solid&#39; Q3 report\" data-tweet=\"$DOCU $ADBE - DOCU target raised before &#39;solid&#39; Q3 report https://seekingalpha.com/news/3522850-docu-target-raised-solid-q3-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3522850-docu-target-raised-solid-q3-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}